"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. . "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. diprophylline or dyphylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c10h14n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 263t0e9rr9, chemically known as 1,3-dimethyl-7-(2,3-dihydroxypropyl)xanthine but generally known as diprophylline, which bears us nih compound identifier 3182. european medicines agency schedules diprophylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07225mig. the term diprophylline is an international non-proprietary name. world health organization schedules diprophylline in its anatomical therapeutic chemical (atc) classification. diprophylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. diprophylline or dyphylline bears us nlm identifiers umls id c0721457 and nci concept code c47504. smiles: cn1c2=c(c(=o)n(c1=o)c)n(c=n2)cc(co)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. montelukast. this classification denotes a bronchodilator, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mhm278sd3e. european medicines agency schedules montelukast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09054mig. montelukast generally arises in the molecular formula c35h36clno3s. the term montelukast is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36.) montelukast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule montelukast under hs 29334990 and sitc 51575. as of q4 2014, montelukast remains the us fda preferred term for this commodity. montelukast bears us nlm identifiers umls id c0298130 and nci concept code c66189. smiles: clc1cc2nc(/c=c/c3cc(c(scc4(cc4)cc(=o)o)ccc4c(c(o)(c)c)cccc4)ccc3)ccc2cc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. zileuton. this classification denotes a lipooxygenase inhibitor with the molecular formula c11h12n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v1l22wve2s, chemically known as urea, n-(1-benzo(b)thien-2-ylethyl)-n-hydroxy- but generally known as zileuton, which bears us nih compound identifier 60490. european medicines agency schedules zileuton in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00157mig. the term zileuton is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). zileuton is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zileuton under hs 29349990 and sitc 51579. as of q4 2014, zileuton remains the us fda preferred term for this commodity. zileuton bears us nlm identifiers umls id c0081408 and nci concept code c26667. smiles: cc(c1=cc2=cc=cc=c2s1)n(c(=o)n)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. pranlukast. this classification denotes an anti-asthmatic agent and leukotriene antagonist with the molecular formula c27h23n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tb8z891092, chemically known as benzamide, n-(4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)- but generally known as pranlukast, which bears us nih compound identifier 115100. european medicines agency schedules pranlukast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09998mig. world health organization schedules pranlukast in its anatomical therapeutic chemical (atc) classification. pranlukast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pranlukast under hs 29349990 and sitc 51579. as of q4 2014, pranlukast remains the us fda preferred term for this commodity. pranlukast bears us nlm identifiers umls id c0526058 and nci concept code c96712. smiles: o(ccccc1ccccc1)c1ccc(cc1)c(=o)nc1cc2oc(cc(=o)c2cc1)c1n[nh]nn1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. carmoterol. this classification denotes an antiasthmatic drug with the molecular formula c21h24n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9810nul4d1, chemically known as 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-1h-quinolin-2-one but generally known as carmoterol, which bears us nih compound identifier 63952. european medicines agency schedules aarmoterol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25400. the term carmoterol is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53.). most nations schedule carmoterol under hs 29337900 and sitc 51561. as of q4 2014, carmoterol remains the us fda preferred term for this commodity. smiles: cc(cc1=cc=c(c=c1)oc)ncc(c2=c3c=cc(=o)nc3=c(c=c2)o)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. cilomilast. this classification denotes a phosphodiesterase inhibitor with the molecular formula c20h25no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8atb1c1r6x, chemically known as cyclohexanecarboxylic acid, 4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)-, cis- but generally known as cilomilast, which bears us nih compound identifier 151170. european medicines agency schedules cilomilast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01296mig. the term cilomilast is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule cilomilast under hs 29269095 and sitc 51484. as of q4 2014, cilomilast remains the us fda preferred term for this commodity. cilomilast bears us nlm identifiers umls id c0968887 and nci concept code c95232. smiles: o(c1cccc1)c1cc(c2(ccc(cc2)c(=o)o)c#n)ccc1oc.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. tiotropium. this classification denotes an antimuscarinic agent with the molecular formula c19h22no4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0eb439235f, chemically known as 7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide but generally known as tiotropium, which bears us nih compound identifier 5487426. european medicines agency schedules tiotropium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25691. tiotropium is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, tiotropium remains the us fda preferred term for this commodity. tiotropium bears us nlm identifiers umls id c0213771 and nci concept code c76004. smiles: br.s1c(c(o)(c(=o)oc2cc3[n](c(c4oc34)c2)(c)c)c2sccc2)ccc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. dazoquinast. this classification denotes an anti-asthmatic agent with the molecular formula c11h7n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a16f9min3z, chemically known as imidazo(1,2-a)quinoxaline-2-carboxylic acid but generally known as dazoquinast, which bears us nih compound identifier 71146. european medicines agency schedules dazoquinast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06924mig. the term dazoquinast is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). dazoquinast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dazoquinast under hs 29339990 and sitc 51577. as of q4 2014, dazoquinast remains the us fda preferred term for this commodity. dazoquinast bears us nlm identifiers umls id c2699564 and nci concept code c75138. smiles: c1=cc=c2c(=c1)n=cc3=nc(=cn23)c(=o)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. ablukast. this classification denotes an anti-asthmatic agent with the molecular formula c28h34o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 000tkm5bbq, chemically known as 2h-1-benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, (+-)- but generally known as ablukast, which bears us nih compound identifier 57109. ablukast most often appears in sodium form. european medicines agency schedules ablukast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07363mig. the term ablukast is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). ablukast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ablukast under hs 29329985 and sitc 51569. as of q4 2014, ablukast remains the us fda preferred term for this commodity. ablukast bears us nlm identifiers umls id c0073512 and nci concept code c74132. smiles: o1c(ccc2c1cc(occcccoc1c(ccc)c(o)c(cc1)c(=o)c)c(c2)c(=o)c)c(=o)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. acitazanolast. this classification denotes an anti-asthmatic agent with the molecular formula c9h7n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 99y8vj356g, chemically known as oxanilic acid, 3-(1h-tetrazol-5-yl)- but generally known as acitazanolast, which bears us nih compound identifier 2006. acitazanolast comes in base and hydrate forms. european medicines agency schedules acitazanolast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05238mig. the term acitazanolast is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). acitazanolast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acitazanolast under hs 29339990 and sitc 51577. as of q4 2014, acitazanolast remains the us fda preferred term for this commodity. acitazanolast bears us nlm identifiers umls id c0642373 and nci concept code c74133. smiles: o=c(nc1cc(ccc1)c1n[nh]nn1)c(=o)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. acreozast. this classification denotes an anti-asthmatic agent with the molecular formula c15h14cln3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84dz9rw4wk, chemically known as 3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile but generally known as acreozast, which bears us nih compound identifier 129991. european medicines agency schedules acreozast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05248mig. the term acreozast is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 1 1998, list 39). acreozast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acreozast under hs 29269095 and sitc 51484. as of q4 2014, acreozast remains the us fda preferred term for this commodity. acreozast bears us nlm identifiers umls id c2347176 and nci concept code c74131. smiles: clc1c(nc(=o)coc(=o)c)cc(cc1nc(=o)coc(=o)c)c#n.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. amipizone. this classification denotes a phosphodiesterase inhibitor with the molecular formula c14h16cln3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7ot95q2g4e, chemically known as 6-(p-(2-chloropropionylamino)phenyl)-5-methyl-4,5-dihydropyridazin-3-one but generally known as amipizone, which bears us nih compound identifier 68889. european medicines agency schedules amipizone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05454mig. the term amipizone is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). amipizone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amipizone under hs 29339990 and sitc 51577. as of q4 2014, amipizone remains the us fda preferred term for this commodity. amipizone bears us nlm identifiers umls id c2698092 and nci concept code c74345. smiles: clc(c(=o)nc1ccc(c2=nnc(=o)cc2c)cc1)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. arofylline. this classification denotes a phosphodiesterase inhibitor with the molecular formula c14h13cln4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 87l38ay71r, chemically known as 3-(4-chlorophenyl)-1-propyl-3,7-dihydro-1h-purine-2,6-dione but generally known as arofylline, which bears us nih compound identifier 166553. european medicines agency schedules arofylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05566mig. the term arofylline is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). most nations schedule arofylline under hs 29395900 and sitc 54145. as of q4 2014, arofylline remains the us fda preferred term for this commodity. arofylline bears us nlm identifiers umls id c2698184 and nci concept code c74223. smiles: clc1ccc(n2c3nc[nh]c3c(=o)n(ccc)c2=o)cc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. binizolast. this classification denotes an anti-asthmatic agent with the molecular formula c18h23n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w2kgp0434y, chemically known as 1-(piperidinomethyl)-4-propyl-s-triazolo(4,3-a)quinazolin-5(4h)-one but generally known as binizolast, which bears us nih compound identifier 185461. european medicines agency schedules binizolast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05838mig. the term binizolast is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). binizolast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule binizolast under hs 29335995 and sitc 51576. as of q4 2014, binizolast remains the us fda preferred term for this commodity. binizolast bears us nlm identifiers umls id c2347021 and nci concept code c74130. smiles: o=c1n(c2n(c(nn2)cn2ccccc2)c2c1cccc2)ccc.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. isbufylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c11h16n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9c8z5f38d0, chemically known as 3,7-dihydro-1,3-dimethyl-7-(2-methylpropyl)-1h-purine-2,6-dione but generally known as isbufylline, which bears us nih compound identifier 65681. european medicines agency schedules isbufylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08308mig. the term isbufylline is an international non-proprietary name. isbufylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isbufylline under hs 29395900 and sitc 54145. as of q4 2014, isbufylline remains the us fda preferred term for this commodity. isbufylline bears us nlm identifiers umls id c0043937 and nci concept code c65970. smiles: cc(c)cn1c=nc2=c1c(=o)n(c(=o)n2c)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. denbufylline. this classification denotes a phosphodiesterase inhibitor with the molecular formula c16h24n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 04b949ko6f, chemically known as 3,7-dihydro-1,3-dibutyl-7-(2-oxopropyl)-1h-purine-2,6-dione but generally known as denbufylline, which bears us nih compound identifier 2984. european medicines agency schedules denbufylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06974mig. the term denbufylline is an international non-proprietary name. denbufylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule denbufylline under hs 29395900 and sitc 54145. as of q4 2014, denbufylline remains the us fda preferred term for this commodity. denbufylline bears us nlm identifiers umls id c0057384 and nci concept code c76316. smiles: o=c1n(c2ncn(c2c(=o)n1cccc)cc(=o)c)cccc.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. dimabefylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c16h19n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l6v4z7sx7s, chemically known as 7-(p-dimethylaminobenzyl)-1,3-dimethylxanthine but generally known as dimabefylline, which bears us nih compound identifier 71646. european medicines agency schedules dimabefylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07149mig. the term dimabefylline is an international non-proprietary name. dimabefylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dimabefylline under hs 29395900 and sitc 54145. as of q4 2014, dimabefylline remains the us fda preferred term for this commodity. dimabefylline bears us nlm identifiers umls id c1880329 and nci concept code c65392. smiles: o=c1n(c(=o)n(c2ncn(c12)cc1ccc(n(c)c)cc1)c)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. doxofylline. this classification denotes a phosphodiesterase inhibitor with the molecular formula c11h14n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mpm23gmo7z, chemically known as 7-(1,3-dioxolon-2-ylmethyl)-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-purindion but generally known as doxofylline, which bears us nih compound identifier 50942. european medicines agency schedules doxofylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06390mig. the term doxofylline is an international non-proprietary name. world health organization schedules doxofylline in its anatomical therapeutic chemical (atc) classification. doxofylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doxofylline under hs 29395900 and sitc 54145. as of q4 2014, doxofylline remains the us fda preferred term for this commodity. doxofylline bears us nlm identifiers umls id c0058721 and nci concept code c76317. smiles: cn1c2=c(c(=o)n(c1=o)c)n(c=n2)cc3occo3.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. enofelast. this classification denotes an anti-asthmatic agent with the molecular formula c16h15fo, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3t93ts0430, chemically known as 2,6-dimethyl-4-(2-(4-fluorophenyl)ethenyl)phenol but generally known as enofelast, which bears us nih compound identifier 6439222. european medicines agency schedules enofelast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06538mig. the term enofelast is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). enofelast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enofelast under hs 29081900 and sitc 51244. as of q4 2014, enofelast remains the us fda preferred term for this commodity. enofelast bears us nlm identifiers umls id c0091793 and nci concept code c74134. smiles: fc1ccc(/c=c/c2cc(c(o)c(c2)c)c)cc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. eprozinol. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h30n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ij21ak8ivj, chemically known as 1-piperazinepropanol, 4-(beta-methoxyphenethyl)-alpha-phenyl- but generally known as eprozinol, which bears us nih compound identifier 122553. european medicines agency schedules eprozinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06589mig. the term eprozinol is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules eprozinol in its anatomical therapeutic chemical (atc) classification. eprozinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eprozinol under hs 29335995 and sitc 51576. as of q4 2014, eprozinol remains the us fda preferred term for this commodity. eprozinol bears us nlm identifiers umls id c0059471 and nci concept code c65522. smiles: o(c(cn1ccn(cc1)ccc(o)c1ccccc1)c1ccccc1)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. etamiphyllin or etamiphylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c13h21n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 221a91bq2s, chemically known as 1,3-dimethyl-7-(2-(diethylamino)ethyl)xanthine but generally known as etamiphyllin, which bears us nih compound identifier 28329. european medicines agency schedules etamiphyllin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13725mig. the term etamiphyllin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules etamiphyllin in its anatomical therapeutic chemical (atc) classification. etamiphyllin or etamiphylline bears us nlm identifiers umls id c0059680 and nci concept code c65551. smiles: o=c1n(c(=o)n(c2ncn(ccn(cc)cc)c12)c)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. flufylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c21h24fn5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o8g173034u, chemically known as 1h-purine-2,6-dione, 7-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-3,7-dihydro-1,3-dimethyl- but generally known as flufylline, which bears us nih compound identifier 71255. european medicines agency schedules flufylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07689mig. the term flufylline is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). flufylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flufylline under hs 29395900 and sitc 54145. as of q4 2014, flufylline remains the us fda preferred term for this commodity. flufylline bears us nlm identifiers umls id c0060489 and nci concept code c65712. smiles: fc1ccc(c(=o)c2ccn(cc2)ccn2c3c(n(c(=o)n(c3=o)c)c)nc2)cc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. fluprofylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c22h26fn5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6y42k4jrbj, chemically known as 1h-purine-2,6-dione, 7-(3-(4-(4-fluorobenzoyl)-1-piperidinyl)propyl)-3,7-dihydro-1,3-dimethyl- but generally known as fluprofylline, which bears us nih compound identifier 65636. european medicines agency schedules fluprofylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07738mig. the term fluprofylline is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). fluprofylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fluprofylline under hs 29395900 and sitc 54145. as of q4 2014, fluprofylline remains the us fda preferred term for this commodity. fluprofylline bears us nlm identifiers umls id c1880820 and nci concept code c65732. smiles: fc1ccc(c(=o)c2ccn(cc2)cccn2c3c(n(c(=o)n(c3=o)c)c)nc2)cc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. furafylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c12h12n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c2087g0xx3, chemically known as 3-furfuryl-1,8-dimethylxanthine but generally known as furafylline, which bears us nih compound identifier 3433. european medicines agency schedules furafylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07829mig. the term furafylline is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). furafylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule furafylline under hs 29395900 and sitc 54145. as of q4 2014, furafylline remains the us fda preferred term for this commodity. furafylline bears us nlm identifiers umls id c0060848 and nci concept code c65779. smiles: cc1=nc2=c(n1)c(=o)n(c(=o)n2cc3=cc=co3)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. oxarbazole. this classification denotes an anti-asthmatic agent with the molecular formula c21h19no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a34ych7n8a, chemically known as 9-benzoyl-1,2,3,4-tetrahydro-6-methoxycarbazole-3-carboxylic acid but generally known as oxarbazole, which bears us nih compound identifier 37184. european medicines agency schedules oxarbazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09503mig. the term oxarbazole is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). oxarbazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxarbazole under hs 29339990 and sitc 51577. as of q4 2014, oxarbazole remains the us fda preferred term for this commodity. oxarbazole bears us nlm identifiers umls id c0069741 and nci concept code c81436. smiles: oc(=o)c1cc2c(n(c3c2cc(oc)cc3)c(=o)c2ccccc2)cc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. lomifylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c13h18n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier na91gv8gdj, chemically known as 1,2,3,6-tetrahydro-1,3-dimethyl-7-(5-oxohexyl)purin-2,6-dion but generally known as lomifylline, which bears us nih compound identifier 65599. european medicines agency schedules lomifylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08566mig. the term lomifylline is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). lomifylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lomifylline under hs 29395900 and sitc 54145. as of q4 2014, lomifylline remains the us fda preferred term for this commodity. lomifylline bears us nlm identifiers umls id c0614278 and nci concept code c66030. smiles: o=c1n(c(=o)n(c2ncn(ccccc(=o)c)c12)c)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. melquinast. this classification denotes an anti-asthmatic agent with the molecular formula c15h16n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0ro0seu9ay, chemically known as ethyl 6-ethyl-5,6-dihydro-9-methyl-5-oxo-s-triazolo(1,5-c)quinazoline-2-carboxylate. but generally known as melquinast, which bears us nih compound identifier 3045413. european medicines agency schedules melquinast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08729mig. the term melquinast is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). melquinast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule melquinast under hs 29335995 and sitc 51576. as of q4 2014, melquinast remains the us fda preferred term for this commodity. melquinast bears us nlm identifiers umls id c1881774 and nci concept code c66082. smiles: o=c1n(c2c(c3n1nc(n3)c(=o)occ)cc(cc2)c)cc.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. midaxifylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c16h25n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a937z0ms6c, chemically known as 8-(1-aminocyclopentyl)-1,3-dipropylxanthine but generally known as midaxifylline, which bears us nih compound identifier 3047747. european medicines agency schedules midaxifylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03288mig. the term midaxifylline is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 1, 1999, list 41). most nations schedule midaxifylline under hs 29395900 and sitc 54145. as of q4 2014, midaxifylline remains the us fda preferred term for this commodity. midaxifylline bears us nlm identifiers umls id c1881825 and nci concept code c66147. smiles: o=c1n(c(=o)n(c2nc([nh]c12)c1(n)cccc1)ccc)ccc.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. motapizone. this classification denotes a phosphodiesterase inhibitor with the molecular formula c12h12n4os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c4a61p8a37, chemically known as 3(2h)-pyridazinone, 4,5-dihydro-6-(4-imidazol-1-yl-2-thienyl)-5-methyl- but generally known as motapizone, which bears us nih compound identifier 65819. european medicines agency schedules motapizone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09075mig. the term motapizone is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). motapizone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule motapizone under hs 29349990 and sitc 51579. as of q4 2014, motapizone remains the us fda preferred term for this commodity. motapizone bears us nlm identifiers umls id c0066826 and nci concept code c66205. smiles: cc1cc(=o)nn=c1c2=cc(=cs2)n3c=cn=c3.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. nepadutant. this classification denotes an anti-asthmatic agent with the molecular formula c45h58n10o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xw59tyl1xh, chemically known as men-11,420 but generally known as nepadutant, which bears us nih compound identifier 3086682. european medicines agency schedules nepadutant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09196mig. the term nepadutant is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). nepadutant is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nepadutant under hs 29349990 and sitc 51579. as of q4 2014, nepadutant remains the us fda preferred term for this commodity. nepadutant bears us nlm identifiers umls id c0664922 and nci concept code c84001. smiles: o1c(nc(=o)cc(n)c(=o)nc2cc(=o)ncc(nc(=o)c(nc(=o)c(nc2=o)cc2c3c([nh]c2)cccc3)cc2ccccc2)c(=o)nc(cc(c)c)c(=o)o)c(nc(=o)c)c(o)c(o)c1co.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. nestifylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c11h14n4o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 52915asm3d, chemically known as 3,7-dihydro-1,3-dimethyl-7-(1,3-dithiolan-2-ylmethyl)-1h-purine-2,6-dione but generally known as nestifylline, which bears us nih compound identifier 65931. european medicines agency schedules nestifylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09209mig. the term nestifylline is an international non-proprietary name. nestifylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nestifylline under hs 29395900 and sitc 54145. as of q4 2014, nestifylline remains the us fda preferred term for this commodity. nestifylline bears us nlm identifiers umls id c1882069 and nci concept code c66234. smiles: cn1c2=c(c(=o)n(c1=o)c)n(c=n2)cc3sccs3.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. ontazolast. this classification denotes an anti-asthmatic agent with the molecular formula c21h25n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8p8tw6b25i, chemically known as 2-benzoxazolamine, n-(2-cyclohexyl-1-(2-pyridinyl)ethyl)-5-methyl-, (s)- but generally known as ontazolast, which bears us nih compound identifier 71458. european medicines agency schedules ontazolast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09446mig. the term ontazolast is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). ontazolast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ontazolast under hs 29349990 and sitc 51579. as of q4 2014, ontazolast remains the us fda preferred term for this commodity. ontazolast bears us nlm identifiers umls id c0663012 and nci concept code c79123. smiles: o1c(nc(cc2ccccc2)c2ncccc2)nc2c1ccc(c2)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. perbufylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m69h5tdq1k. european medicines agency schedules perbufylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09717mig. perbufylline generally arises in the molecular formula c23h28fn5o3. the term perbufylline is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28.) perbufylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule perbufylline under hs 29395900 and sitc 54145. as of q4 2014, perbufylline remains the us fda preferred term for this commodity. perbufylline bears us nlm identifiers umls id c1882325 and nci concept code c66354. smiles: fc1ccc(c(=o)c2ccn(cc2)ccccn2c3c(n(c(=o)n(c3=o)c)c)nc2)cc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. pirolate. this classification denotes an anti-asthmatic agent with the molecular formula c16h15n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2lf7l6qd58, chemically known as pyrimido(4,5-b)quinoline-2-carboxylic acid, 1,4-dihydro-7,8-dimethoxy-4-oxo-, ethyl ester but generally known as pirolate, which bears us nih compound identifier 5361200. european medicines agency schedules pirolate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09932mig. the term pirolate is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). pirolate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pirolate under hs 29335995 and sitc 51576. as of q4 2014, pirolate remains the us fda preferred term for this commodity. pirolate bears us nlm identifiers umls id c2826064 and nci concept code c82231. smiles: o(c1cc2c(nc3[nh]c(nc(=o)c3c2)c(=o)occ)cc1oc)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. proxyphylline. this classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula c10h14n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 13g1dmn4p0, chemically known as 3,7-dihydro-7-(2-hydroxypropyl)-1,3-dimethyl-1h-purine-2,6-dione but generally known as proxyphylline, which bears us nih compound identifier 4977. european medicines agency schedules proxyphylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10153mig. the term proxyphylline is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules proxyphylline in its anatomical therapeutic chemical (atc) classification. proxyphylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule proxyphylline under hs 29395900 and sitc 54145. as of q4 2014, proxyphylline remains the us fda preferred term for this commodity. proxyphylline bears us nlm identifiers umls id c0072511 and nci concept code c80339. smiles: cc(cn1c=nc2=c1c(=o)n(c(=o)n2c)c)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. ritolukast. this classification denotes an anti-asthmatic agent with the molecular formula c17h13f3n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0e8r4gde2q, chemically known as 1,1,1-trifluoro-alpha-2-quinolylmethanesulfon-m-anisidide but generally known as ritolukast, which bears us nih compound identifier 60539. european medicines agency schedules ritolukast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10341mig. the term ritolukast is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). most nations schedule ritolukast under hs 29350090 and sitc 51580. as of q4 2014, ritolukast remains the us fda preferred term for this commodity. ritolukast bears us nlm identifiers umls id c2347965 and nci concept code c74129. smiles: s(=o)(=o)(nc1cc(occ2nc3c(cc2)cccc3)ccc1)c(f)(f)f.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. seratrodast. this classification denotes an anti-asthmatic agent with the molecular formula c22h26o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4u58jm421n, chemically known as benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)- but generally known as seratrodast, which bears us nih compound identifier 2449. european medicines agency schedules seratrodast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10490mig. the term seratrodast is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules seratrodast in its anatomical therapeutic chemical (atc) classification. most nations schedule seratrodast under hs 29183000 and sitc 51395. as of q4 2014, seratrodast remains the us fda preferred term for this commodity. seratrodast bears us nlm identifiers umls id c0050339 and nci concept code c90671. smiles: o=c1c(=c(c(=o)c(=c1c)c)c)c(cccccc(=o)o)c1ccccc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. tomelukast. this classification denotes an anti-asthmatic agent with the molecular formula c16h22n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 59762x5cls, chemically known as ly-171,883 but generally known as tomelukast, which bears us nih compound identifier 3969. european medicines agency schedules tomelukast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11184mig. the term tomelukast is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). tomelukast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tomelukast under hs 29339990 and sitc 51577. as of q4 2014, tomelukast remains the us fda preferred term for this commodity. tomelukast bears us nlm identifiers umls id c2348803 and nci concept code c74135. smiles: o(ccccc1n[nh]nn1)c1c(ccc)c(o)c(cc1)c(=o)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. zardaverine. this classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tq358gwh6y. european medicines agency schedules zardaverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00142mig. zardaverine generally arises in the molecular formula c12h10f2n2o3. the term zardaverine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) zardaverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zardaverine under hs 29339990 and sitc 51577. as of q4 2014, zardaverine remains the us fda preferred term for this commodity. zardaverine bears us nlm identifiers umls id c0085049 and nci concept code c66686. smiles: coc1=c(c=cc(=c1)c2=nnc(=o)c=c2)oc(f)f.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. nivimedone. this classification denotes a mast cell stabilizer with the molecular formula c11h9no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 1m887244yi chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-) but generally known as nivimedone, which bears us nih compound identifier 64753. european medicines agency schedules nivimedone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09333mig. the term nivimedone is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). most nations schedule nivimedone under hs 29147000 and sitc 51629. as of q4 2014, nivimedone remains the us fda preferred term for this commodity. nivimedone bears us nlm identifiers umls id c0068885 and nci concept code c84021. smiles: cc1=c(c=c2c(=c1)c(=o)c(c2=o)[n+](=o)[o-])c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. cromitrile. this classification denotes an anti-asthmatic agent with the molecular formula c20h15n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, w6v355n614 chemically known as benzonitrile, 4-(2-hydroxy-3-((4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-5-yl)oxy)propoxy)-, (+/-)- but generally known as cromitrile, which bears us nih compound identifier 40857. european medicines agency schedules cromitrile in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06823mig. the term cromitrile is an international non-proprietary name or inn. most nations schedule cromitrile under hs 29349990 and sitc 51579. as of q4 2014, cromitrile remains the us fda preferred term for this commodity. cromitrile bears us nlm identifiers umls id c2825629 and nci concept code c81437. smiles: o(cc(o)coc1ccc(cc1)c#n)c1c2c(oc(cc2=o)c2n[nh]nn2)ccc1.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. nisbuterol. this classification denotes an anti-asthmatic agent with the molecular formula c22h27no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nkl13v61jh, chemically known as [2-acetyloxy-4-[2-(tert-butylamino)-1-hydroxyethyl]phenyl]4-methoxybenzoate but generally known as nisbuterol, which bears us nih compound identifier 3047793. european medicines agency schedules nisbuterol its extended eudravigilance medicinal product dictionary or xevmpd under index sub09305mig. most nations schedule nisbuterol under hs 29225000 and sitc 51467. as of q4 2014, nisbuterol remains the us fda preferred term for this commodity. nisbuterol bears us nlm identifiers umls id c2983896 and nci concept code c90819. smiles: cc(=o)oc1=c(c=cc(=c1)c(cnc(c)(c)c)o)oc(=o)c2=cc=c(c=c2)oc.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. pirquinozol. this classification denotes an anti-asthmatic agent with the molecular formula c11h9n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d16hg4v2uc, chemically known as 2-(hydroxymethyl)pyrazolo(1,5-c)quinazolin-5(6h)-one but generally known as pirquinozol, which bears us nih compound identifier 47783. european medicines agency schedules pirquinozol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09941mig. the term pirquinozol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). pirquinozol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pirquinozol under hs 29335995 and sitc 51576. as of q4 2014, pirquinozol remains the us fda preferred term for this commodity. pirquinozol bears us nlm identifiers umls id c0071153 and nci concept code c90669. smiles: c1=cc2=c3c=c(nn3c(=o)n=c2c=c1)co.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. norethindrone and ethinyl estradiol combination. this classification denotes a mast cell stabilizer with the molecular structure c11h9no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 1m887244yi chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-) but generally known as nivimedone, which bears us nih compound identifier 64753. european medicines agency schedules nivimedone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09333mig. the term nivimedone is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). smiles: cc1=c(c=c2c(=c1)c(=o)c(c2=o)[n+](=o)[o-])c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. zafirlukast. this classification denotes an anti-asthmatic agent with the molecular formula c31h33n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xz629s5l50, chemically known as ici 204,219 but generally known as zafirlukast, which bears us nih compound identifier 5717. european medicines agency schedules zafirlukast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00128mig. the term zafirlukast is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules zafirlukast in its anatomical therapeutic chemical (atc) classification. zafirlukast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zafirlukast under hs 29350090 and sitc 51580. as of q4 2014, zafirlukast remains the us fda preferred term for this commodity. zafirlukast bears us nlm identifiers umls id c0378466 and nci concept code c47785. smiles: s(=o)(=o)(nc(=o)c1cc(oc)c(cc2c3c(n(c2)c)ccc(nc(=o)oc2cccc2)c3)cc1)c1c(cccc1)c.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. ablukast sodium. this classification denotes an anti-asthmatic agent with the molecular formula c28h33o8.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 37bxz0j2rt, chemically known as 2h-1-benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, monosodium salt, ( -); but more generally known as ablukast sodium, which bears us nih compound identifier 57108. most nations, for tariff and trade purposes, schedule ablukast sodium under hs 29329985 and sitc 51569. as of q4 2014, ablukast sodium remains us fdas preferred term for this commodity. ablukast sodium bears us nlm identifiers umls id c2827073 and nci concept code c83514. smiles: cccc1c(ccc(c1o)c(=o)c)occcccoc2cc3c(cc2c(=o)c)ccc(o3)c(=o)[o-].[na+].. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. acitazanolast hydrate. this classification denotes an anti-asthmatic agent with the molecular structure c9h7n5o3.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, u6su9zsu4k chemically known as acetic acid, 2-oxo-2-((3-(2h-tetrazol-5-yl)phenyl)amino)-, hydrate (1:1), but more commonly known as acitazanolast hydrate, which bears us nih compound identifier 11954321. european medicines agency schedules acitazanolast hydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub33524. most nations, for tariff and trade purposes, schedule acitazanolast hydrate under hs 29339990. smiles: c1cc(cc(c1)nc(=o)c(=o)o)c2[nh]nnn2.o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. cromitrile sodium. this classification denotes an anti-asthmatic agent with the molecular formula c20h14n5o5.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z9fyz8p9nd, chemically known as benzonitrile, 4-(2-hydroxy-3-((4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-5-yl)oxy)propoxy)-,monosodium salt but more generally known as cromitrile sodium, which bears us nih compound identifier 40856. most nations, for tariff and trade purposes, schedule cromitrile sodium under hs 29349990 and sitc 51579. as of q4 2014, cromitrile sodium remains us fdas preferred term for this commodity. cromitrile sodium bears us nlm identifiers umls id c2825630 and nci concept code c81438. smiles: c1cc2c(c(c1)occ(coc3ccc(cc3)c#n)o)c(=o)cc(o2)c4[n-]nnn4.[na+].. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. eprozinol dihydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h30n2o2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x9ami360pi, chemically known as 1-piperazinepropanol, 4-(2-methoxy-2-phenylethyl)-.alpha.-phenyl-, hydrochloride (1:2), but more generally known as eprozinol dihydrochloride, which bears us nih compound identifier 161574. european medicines agency schedules eprozinol dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06589mig. most nations, for tariff purposes, schedule eprozinol dihydrochloride under hs 29335995. smiles: coc(cn1ccn(cc1)ccc(c2ccccc2)o)c3ccccc3.cl.cl.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. eprozinol hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h30n2o2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x9ami360pi. european medicines agency schedules eprozinol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01921mig. the term eprozinol hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule eprozinol hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, eprozinol hydrochloride remains us fdas preferred term for this commodity. smiles: coc(cn1ccn(cc1)ccc(c2ccccc2)o)c3ccccc3.cl.cl.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. montelukast sodium. this classification denotes an anti-asthmatic agent with the molecular formula c35h35clno3s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u1o3j18sfl, chemically known as cyclopropaneacetic acid, 1-((((1r)-1-(3-((1e)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, monosodium salt but more generally known as montelukast sodium, which bears us nih compound identifier 5281041. european medicines agency schedules montelukast sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03324mig. most nations, for tariff and trade purposes, schedule montelukast sodium under hs 29334990 and sitc 51575. as of q4 2014, montelukast sodium remains us fdas preferred term for this commodity. montelukast sodium bears us nlm identifiers umls id c0380447 and nci concept code c47625. smiles: cc(c)(c1ccccc1cc[c@h](c2cccc(c2)/c=c/c3ccc4ccc(cc4n3)cl)scc5(cc5)cc(=o)[o-])o.[na+].. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. nisbuterol mesilate or mesylate. this classification denotes an anti-asthmatic agent with the molecular formula c22h27no6.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4zsf6gbg5s, chemically known as benzoic acid, 4-methoxy-, 2-(acetyloxy)-4-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)phenyl ester, methanesulfonate (salt) but more generally known as nisbuterol mesylate, which bears us nih compound identifier 3047792. most nations, for tariff and trade purposes, schedule nisbuterol mesylate under hs 29225000. as of q4 2014, nisbuterol mesylate remains us fdas preferred term for this commodity. nisbuterol mesylate bears us nlm identifiers umls id c2698474 and nci concept code c75139. smiles: cc(=o)oc1cc(ccc1oc(=o)c2ccc(cc2)oc)c(cnc(c)(c)c)o.cs(=o)(=o)o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. nivimedone sodium. this classification denotes a mast cell stabilizer with the molecular formula c11h8no4.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4953c873n2, chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-), sodium, monohydrate but more generally known as nivimedone sodium, which bears us nih compound identifier 43916. most nations, for tariff and trade purposes, schedule nivimedone sodium under hs 29147000 and sitc 51629. as of q4 2014, nivimedone sodium remains us fdas preferred term for this commodity. nivimedone sodium bears us nlm identifiers umls id c0132621 and nci concept code c72941. smiles: cc1cc2c(cc1c)c(=o)c(=[n+]([o-])[o-])c2=o.o.[na+].. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. nivimedone sodium anhydrous. this classification denotes a mast cell stabilizer with the molecular formula c11h8no4.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50hx07baju, chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-), sodium (1:1), but more generally known as nivimedone sodium anhydrous, which bears us nih compound identifier 64752. european medicines agency schedules nivimedone sodium anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09333mig. most nations, for tariff purposes, schedule nivimedone sodium anhydrous under hs 29147000. smiles: cc1cc2c(cc1c)c(=o)c(=[n+]([o-])[o-])c2=o.[na+].. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. pranlukast hydrate. this classification denotes an anti-asthmatic agent and leukotriene antagonist with the molecular formula 2c27h23n5o4.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fr702n558k, chemically known as benzamide, n-(4-oxo-2-(2h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-, hydrate (2:1), but more generally known as pranlukast hydrate, which bears us nih compound identifier 5311184. european medicines agency schedules pranlukast hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09998mig. most nations, for tariff purposes, schedule pranlukast hydrate under hs 29349990. smiles: c1ccc(cc1)ccccoc2ccc(cc2)c(=o)nc3cccc4c3oc(cc4=o)c5[nh]nnn5.c1ccc(cc1)ccccoc2ccc(cc2)c(=o)nc3cccc4c3oc(cc4=o)c5[nh]nnn5.o.. "
"antiasthmatic drugs. this classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.. tiotropium bromide. this classification denotes an antimuscarinic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l64sxo195n. european medicines agency schedules tiotropium bromide monohydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21897. tiotropium bromide generally arises in the molecular formula c19h22no4s2.br.h2o. the term tiotropium bromide is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule tiotropium bromide under hs 29399900 and sitc 54149. as of q4 2014, tiotropium bromide remains us fdas preferred term for this commodity. tiotropium bromide bears us nlm identifiers umls id cl449040 and nci concept code c84608. smiles: c[n+]1([c@@h]2c[c@h](c[c@h]1[c@h]3[c@@h]2o3)oc(=o)c(c4cccs4)(c5cccs5)o)c.[br-].. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. . "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. beractant. this classification denotes a respiratory drug, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s866o45pig.the european medicines agency schedules beractant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13043mig. as of q4 2014, beractant remains the us fda preferred term for this commodity.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. colfosceril. this classification denotes an agent affecting respiratory system with the molecular formula c40h80no8p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 319x2nfw0a, chemically known as 3,5,9-trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxohexadecyl)oxy)-, inner salt, 4-oxide but generally known as colfosceril palmitate, which bears us nih compound identifier 6138. european medicines agency schedules colfosceril palmitate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06799mig. the term colfosceril palmitate is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules colfosceril palmitate in its anatomical therapeutic chemical (atc) classification. smiles: cccccccccccccccc(=o)occ(cop(=o)([o-])occ[n+](c)(c)c)oc(=o)ccccccccccccccc.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. ipratropium bromide. this classification denotes a bronchodilator and antimuscarinic agent with the molecular formula c20h30no3.br.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j697uz2a9j, chemically known as 3-alpha-hydroxy-8-isopropyl-1-alpha-h,5-alpha-h-tropanium bromide (+-)-tropate but generally known as ipratropium bromide, which bears us nih compound identifier 31098. european medicines agency schedules ipratropium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08276mig. world health organization schedules ipratropium bromide in its anatomical therapeutic chemical (atc) classification. most nations schedule ipratropium bromide under hs 29399900 and sitc 54149. as of q4 2014, ipratropium bromide remains the us fda preferred term for this commodity. ipratropium bromide bears us nlm identifiers umls id c0700580 and nci concept code c29128. smiles: br.o(c1cc2[n](c(cc2)c1)(c(c)c)c)c(=o)c(co)c1ccccc1.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. desoxyribonuclease or dornase alfa. this classification denotes an enzyme replacement preparation with the molecular formula c1321h1995n339o396s9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 953a26oa1y, more generally known as dornase alfa. european medicines agency schedules dornase alfa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06373mig. the term dornase alfa is an international non-proprietary name or inn. most nations schedule dornase alfa under hs 35079090 and sitc 51691. as of q4 2014, dornase alfa remains the us fda preferred term for this commodity. dornase alfa bears us nlm identifiers umls id c1135662 and nci concept code c81664. smiles: none.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. poractant alfa. this classification denotes a respiratory drug, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ke3u2023np. amiphenazole most often comes in base and hydrochloride forms. european medicines agency schedules poractant alfa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22150. as of q4 2014, poractant alfa remains the us fda preferred term for this commodity.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. calfactant. this classification denotes a respiratory drug, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q4k217vga9. european medicines agency schedules calfactant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13207mig. as of q4 2014, calfactant remains the us fda preferred term for this commodity.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. mepixanox. this classification denotes an anti-asthmatic agent with the molecular formula c20h21no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7419t4yqqw, chemically known as 9h-xanthen-9-one, 3-methoxy-4-(1-piperidinylmethyl)- but generally known as mepixanox, which bears us nih compound identifier 65687. european medicines agency schedules mepixanox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08754mig. the term mepixanox is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules mepixanox in its anatomical therapeutic chemical (atc) classification. mepixanox is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mepixanox under hs 29349990 and sitc 51579. as of q4 2014, mepixanox remains the us fda preferred term for this commodity. mepixanox bears us nlm identifiers umls id c0071070 and nci concept code c66094. smiles: o1c2c(cn3ccccc3)c(oc)ccc2c(=o)c2c1cccc2.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. almitrine. this classification denotes a cns stimulant with the molecular formula c26h29f2n7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9a1222nbg4, chemically known as 1,3,5-triazine-2,4-diamine, 6-(4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n-di-2-propenyl- but generally known as almitrine, which bears us nih compound identifier 33887. almitrine comes in various forms, including bismesylate, bismethane sulfonate, dimesylate, dimethanesulfonate, and mesylate. european medicines agency schedules almitrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05348mig. the term almitrine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules almitrine in its anatomical therapeutic chemical (atc) classification. almitrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule almitrine under hs 29336980 and sitc 51576. as of q4 2014, almitrine remains the us fda preferred term for this commodity. almitrine bears us nlm identifiers umls id c0002164 and nci concept code c74241. smiles: fc1ccc(c(n2ccn(cc2)c2nc(nc(n2)ncc=c)ncc=c)c2ccc(f)cc2)cc1.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. amiphenazole. this classification denotes a cns stimulant with the molecular formula c9h9n3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7zj8pwy0xd, chemically known as 2,4-thiazolediamine, 5-phenyl- but generally known as amiphenazole, which bears us nih compound identifier 10275. amiphenazole most often comes in base and hydrochloride forms. european medicines agency schedules amiphenazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05453mig. the term amiphenazole is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). amiphenazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amiphenazole under hs 29341000 and sitc 51579. as of q4 2014, amiphenazole remains the us fda preferred term for this commodity. amiphenazole bears us nlm identifiers umls id c0051684 and nci concept code c74238. smiles: s1c(c2ccccc2)c(nc1n)n.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. bemegride. this classification denotes a cns stimulant with the molecular formula c8h13no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 57dqa39do2, chemically known as 3,3-methylethylilotarimide but generally known as bemegride, which bears us nih compound identifier 2310. bemegride most often comes in base or methyl forms. european medicines agency schedules bemegride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05691mig. the term bemegride is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules bemegride in its anatomical therapeutic chemical (atc) classification. bemegride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bemegride under hs 29251995 and sitc 51482. as of q4 2014, bemegride remains the us fda preferred term for this commodity. bemegride bears us nlm identifiers umls id c0004960 and nci concept code c76617. smiles: o=c1nc(=o)cc(c1)(cc)c.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. dimefline. this classification denotes a cns stimulant with the molecular formula c20h21no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9wii5m0du3, chemically known as 4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl- (9ci) but generally known as dimefline, which bears us nih compound identifier 3078. european medicines agency schedules dimefline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07156mig. the term dimefline is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules dimefline in its anatomical therapeutic chemical (atc) classification. dimefline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dimefline under hs 29329985 and sitc 51569. as of q4 2014, dimefline remains the us fda preferred term for this commodity. dimefline bears us nlm identifiers umls id c0058192 and nci concept code c65396. smiles: o1c2c(cn(c)c)c(oc)ccc2c(=o)c(c1c1ccccc1)c.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. doxapram. this classification denotes a cns stimulant with the molecular formula c24h30n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 94f3830q73, chemically known as 2-pyrrolidinone, 1-ethyl-4- (2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride but generally known as doxapram, which bears us nih compound identifier 3156. european medicines agency schedules doxapram in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06382mig. the term doxapram is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules doxapram in its anatomical therapeutic chemical (atc) classification. doxapram is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doxapram under hs 29349990 and sitc 51579. as of q4 2014, doxapram remains the us fda preferred term for this commodity. doxapram bears us nlm identifiers umls id c0013084 and nci concept code c61736. smiles: o=c1n(cc(c1(c1ccccc1)c1ccccc1)ccn1ccocc1)cc.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. fenspiride. this classification denotes a vasodilating agent with the molecular formula c15h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s983qc7hkm, chemically known as 1-oxa-3,8-diazaspiro(4.5)decan-2-one, 8-phenethyl- but generally known as fenspiride, which bears us nih compound identifier 3344. european medicines agency schedules fenspiride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07596mig. the term fenspiride is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules fenspiride in its anatomical therapeutic chemical (atc) classification. fenspiride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenspiride under hs 29349990 and sitc 51579. as of q4 2014, fenspiride remains the us fda preferred term for this commodity. fenspiride bears us nlm identifiers umls id c0015843 and nci concept code c80880. smiles: o1c2(ccn(cc2)ccc2ccccc2)cnc1=o.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. pentetrazol. this classification denotes a convulsant and gaba antagonist with the molecular formula c6h10n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wm5z385k7t, chemically known as 7,8,9,10-tetrazabicyclo(5.3.0)-8,10-decadiene but generally known as pentetrazol, which bears us nih compound identifier 5917. european medicines agency schedules pentetrazol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09690mig. world health organization schedules pentetrazol in its anatomical therapeutic chemical (atc) classification. pentetrazol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pentetrazol under hs 29339990 and sitc 51577. as of q4 2014, pentetrazol remains the us fda preferred term for this commodity. pentetrazol bears us nlm identifiers umls id c0030903 and nci concept code c81054. smiles: c1ccc2=nn=nn2cc1.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. prethcamide. this classification denotes a cns stimulant with the molecular formula c13h24n2o2.c12h22n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 41a1fcw148, chemically known as 2-butenamide, n-(1-((dimethylamino)carbonyl)propyl)-n-ethyl-, mixt. with n-(1-((dimethylamino)carbonyl)propyl)-n-propyl-2-butenamide but generally known as prethcamide, which bears us nih compound identifier 71672. european medicines agency schedules prethcamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35623. world health organization schedules prethcamide in its anatomical therapeutic chemical (atc) classification. as of q4 2014, prethcamide remains the us fda preferred term for this commodity. prethcamide bears us nlm identifiers umls id c0071957 and nci concept code c76627. smiles: o=c(n(c)c)c(n(ccc)c(=o)/c=c/c)cc.o=c(n(c)c)c(n(cc)c(=o)/c=c/c)cc.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. roflumilast. this classification denotes a phosphodiesterase inhibitor with the molecular formula c17h14cl2f2n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0p6c6zop5u, chemically known as 3-cyclopropylmethoxy-n-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide but generally known as roflumilast, which bears us nih compound identifier 449193. european medicines agency schedules roflumilast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10358mig. the term roflumilast is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 1 1998, list 39). world health organization schedules roflumilast in its anatomical therapeutic chemical (atc) classification. roflumilast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule roflumilast under hs 29333999 and sitc 51574. as of q4 2014, roflumilast remains the us fda preferred term for this commodity. roflumilast bears us nlm identifiers umls id c0965618 and nci concept code c76890. smiles: clc1c(nc(=o)c2cc(occ3cc3)c(oc(f)f)cc2)c(cl)cnc1.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. sivelestat. this classification denotes a protease inhibitor with the molecular formula c20h22n2o7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dwi62g0p59, chemically known as o-(p-hydroxybenzenesulfonamido)hippuric acid, pivalate (ester) but generally known as sivelestat, which bears us nih compound identifier 107706. european medicines agency schedules sivelestat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10543mig. the term sivelestat is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). most nations schedule sivelestat under hs 29350090 and sitc 51580. as of q4 2014, sivelestat remains the us fda preferred term for this commodity. sivelestat bears us nlm identifiers umls id c0130137 and nci concept code c66539. smiles: s(=o)(=o)(nc1c(cccc1)c(=o)ncc(=o)o)c1ccc(oc(=o)c(c)(c)c)cc1.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. almitrine bismesylate. this classification denotes a cns stimulant with the molecular formula c26h29f2n7.2ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6ry6v6xm8t, chemically known as 6-4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n-di-2-propenyl-1,3,5-triazine-2,4-diamine dimethanesulfonate, but more generally known as almitrine bismesylate, which bears us nih compound identifier 115048. european medicines agency schedules almitrine bismesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05348mig. most nations, for tariff purposes, schedule almitrine bismesylate under hs 29336980. smiles: cs(=o)(=o)o.cs(=o)(=o)o.c=ccnc1nc(nc(n1)n2ccn(cc2)c(c3ccc(cc3)f)c4ccc(cc4)f)ncc=c.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. almitrine dimesilate. this classification denotes a cns stimulant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6ry6v6xm8t. european medicines agency schedules almitrine dimesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00363mig. almitrine dimesilate generally arises in the molecular formula c26h29f2n7.2ch4o3s. the term almitrine dimesilate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule almitrine dimesilate under hs 29336980 and sitc 51576. smiles: cs(=o)(=o)o.cs(=o)(=o)o.c=ccnc1nc(nc(n1)n2ccn(cc2)c(c3ccc(cc3)f)c4ccc(cc4)f)ncc=c.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. almitrine mesylate. this classification denotes a cns stimulant with the molecular formula c26h29f2n7.2ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6ry6v6xm8t, chemically known as 6-4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n-di-2-propenyl-1,3,5-triazine-2,4-diamine dimethanesulfonate, but more generally known as almitrine mesylate, which bears us nih compound identifier 6918543. european medicines agency schedules almitrine mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05348mig. most nations, for tariff purposes, schedule almitrine mesylate under hs 29336980. as of q4 2014, almitrine mesylate remains us fdas preferred term for this commodity. almitrine mesylate bears us nlm identifiers umls id c0002165 and nci concept code c79962. smiles: cs(=o)(=o)o.cs(=o)(=o)o.c=ccnc1nc(nc(n1)n2ccn(cc2)c(c3ccc(cc3)f)c4ccc(cc4)f)ncc=c.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. amiphenazole hydrochloride. this classification denotes a cns stimulant with the molecular formula c9h9n3s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w6w4748lio, chemically known as 2,4-thiazolediamine, 5-phenyl- but more generally known as amiphenazole hydrochloride, which bears us nih compound identifier 10275. european medicines agency schedules amiphenazole hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00473mig. most nations, for tariff and trade purposes, schedule amiphenazole hydrochloride under hs 29341000 and sitc 51579. as of q4 2014, amiphenazole hydrochloride remains us fdas preferred term for this commodity. smiles: c1ccc(cc1)c2c(nc(s2)n)n.cl.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. dimefline hydrochloride. this classification denotes a cns stimulant with the molecular formula c20h21no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h0xb4r74id, chemically known as 4h-1-benzopyran-4-one, 8-((dimethylamino)methyl)-7-methoxy-3-methyl-2-phenyl- (9ci) but more generally known as dimefline hydrochloride, which bears us nih compound identifier 3078. european medicines agency schedules dimefline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01738mig. most nations, for tariff and trade purposes, schedule dimefline hydrochloride under hs 29329985 and sitc 51569. as of q4 2014, dimefline hydrochloride remains us fdas preferred term for this commodity. dimefline hydrochloride bears us nlm identifiers umls id c0952747 and nci concept code c65397. smiles: cc1c(=o)c2ccc(c(c2oc1c3ccccc3)cn(c)c)oc.cl.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. doxapram hydrochloride. this classification denotes a cns stimulant with the molecular formula c24h30n2o2.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p5ru6uoq5y, chemically known as 2-pyrrolidinone, 1-ethyl-4- (2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride but more generally known as doxapram hydrochloride, which bears us nih compound identifier 3156. european medicines agency schedules doxapram hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01823mig. most nations, for tariff and trade purposes, schedule doxapram hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, doxapram hydrochloride remains us fdas preferred term for this commodity. doxapram hydrochloride bears us nlm identifiers umls id c0699979 and nci concept code c47500. smiles: ccn1cc(c(c1=o)(c2ccccc2)c3ccccc3)ccn4ccocc4.o.cl.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. doxapram hydrochloride anhydrous. this classification denotes a cns stimulant c24h30n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fb8713u6dm, chemically known as (+/-)-1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride, but more generally known as doxapram hydrochloride anhydrous, which bears us nih compound identifier 64647. most nations, for tariff and trade purposes, schedule doxapram hydrochloride anhydrous under hs 29349990 and sitc 51579. as of q4 2014, doxapram hydrochloride anhydrous remains us fdas preferred term for this commodity. smiles: ccn1cc(c(c1=o)(c2ccccc2)c3ccccc3)ccn4ccocc4.cl.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. doxapram hydrochloride hydrate. this classification denotes a cns stimulant with the molecular formula c24h30n2o2.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p5ru6uoq5y, chemically known as 2-pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate, (+/-)-, but more generally known as doxapram hydrochloride hydrate, which bears us nih compound identifier 64648. european medicines agency schedules doxapram hydrochloride hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06382mig. most nations, for tariff purposes, schedule doxapram hydrochloride hydrate under hs 29349990. smiles: ccn1cc(c(c1=o)(c2ccccc2)c3ccccc3)ccn4ccocc4.o.cl.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. fenspiride hydrochloride. this classification denotes a nonsteroidal antiinflammatory drug with the molecular formula c15h20n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 832nbx878v, chemically known as 8-phenethyl-1-oxa-3,8-diazaspiro(4.5)decan-2-one monohydrochloride but more generally known as fenspiride hydrochloride, which bears us nih compound identifier 68626. european medicines agency schedules fenspiride hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02128mig. most nations, for tariff and trade purposes, schedule fenspiride hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, fenspiride hydrochloride remains us fdas preferred term for this commodity. fenspiride hydrochloride bears us nlm identifiers umls id c0771539 and nci concept code c80551. smiles: c1ccc(cc1)ccn2ccc3(cc2)cnc(=o)o3.cl.. "
"drugs used for respiratory tract disorders. this classification denotes drugs that affect the tubular and cavernous organs and structures by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.. ambroxol/salbutamol. this classification denotes a combination drug composed of two constituents: a mucolytic and bronchodilator and beta-adrenergic agonist, as more fully appears. the first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula c13h18br2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 200168s0cl, chemically known as 4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [eu/esis 242-500-3]; ambroxol comes in forms acefyllinate [0hm1e174tn], base, and hydrochloride [cc995zmv90]. european medicines agency schedules ambroxol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05397mig (base), sub12842mig (acefyllinate), and sub00427mig (hydrochloride). the term ambroxol is an international non-proprietary name or inn. world health organization schedules ambroxol in its anatomical therapeutic chemical (atc) classification (r05cb06) and in its who drug dictionary. ambroxol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ambroxol under hs 29221980 and sitc 51461. us census, for industry purposes, classifies ambroxol under naics 325199. the second component of this combination drug, salbutamol (51391703), is a bronchodilator and beta-adrenergic agonist with the molecular formula c13h21no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qf8svz843e, chemically known as 1,3-benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy- but generally known as albuterol, which bears us nih compound identifier 2083. albuterol comes in many forms, including adipate diethanolate, di-methylboronate, n-butylboronate, and sulfate. european medicines agency schedules albuterol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10422mig. the term salbutamol is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules albuterol in its anatomical therapeutic chemical (atc) classification. most nations schedule albuterol under hs 29225090 and sitc 51467. as of q4 2014, albuterol remains the us fda preferred term for this commodity. albuterol bears us nlm identifiers umls id c0001927 and nci concept code c215.. "
"cough and cold and antiallergy products. this classification denotes agents that are used to treat the common cold and similar such maladies. these might treat allergic reactions, decongest, suppress cough, or render coughs more productive. of the allergy-oriented medications, most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells.. . "
"cough and cold and antiallergy products. this classification denotes agents that are used to treat the common cold and similar such maladies. these might treat allergic reactions, decongest, suppress cough, or render coughs more productive. of the allergy-oriented medications, most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells.. combination chlorpheniramine acetaminophen. this classification denotes a combination cough and cold and antiallergy drug. the first component of this drug is a histamine-1 receptor antagonist with the molecular formula c16h19cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3u6io1965u, chemically known as 3-(p-chlorophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but generally known as chlorphenamine, which bears us nih compound identifier 2725. european medicines agency schedules chlorphenamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06201mig. the term chlorphenamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules chlorphenamine in its anatomical therapeutic chemical (atc) classification. chlorphenamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: clc1ccc(c(ccn(c)c)c2ncccc2)cc1. the second component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but generally known as acetaminophen (or paracetamol), which bears us nih compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. smiles: oc1ccc(nc(=o)c)cc1.. "
"cough and cold and antiallergy products. this classification denotes agents that are used to treat the common cold and similar such maladies. these might treat allergic reactions, decongest, suppress cough, or render coughs more productive. of the allergy-oriented medications, most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells.. althaea. this classification denotes a natural product which us fda regulates as an active ingredient or moiety under unique ingredient identifier b3911g2q52 and which the integrated taxonomic information system classifies under taxonomic serial number 21609 as a member of kingdom plantae, subkingdom viridaeplantae, infrakingdom streptophyta, division tracheophyta, subdivision spermatophytina, infradivision angiospermae, class magnoliopsida, superorder rosanae, order malvales, family malvaceae, and genus althaea l., more commonly known as marshmallow. althaea bears the usda plants database identifiers alro3, alro4, alof2, and altha (common variety) and alca25 and alhi2 (palm-leaf and hairy varieties). european medicines agency schedules althaea in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub12803mig, sub12804mig, sub12805mig, sub12806mig, sub33430, and sub35172.. "
"cough and cold and antiallergy products. this classification denotes agents that are used to treat the common cold and similar such maladies. these might treat allergic reactions, decongest, suppress cough, or render coughs more productive. of the allergy-oriented medications, most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells.. tetrahydrozoline. this classification denotes an alpha-adrenergic agonist with the molecular formula c13h16n2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier s9u025y077, chemically known as 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazole but more generally known as tetrahydrozoline, which bears u.s. national institutes of health compound identifier 5419. the european medicines agency schedules tetryzoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10955mig. the term tetryzoline is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). the world health organization schedules tetrahydrozoline in its anatomical therapeutic chemical (atc) classification. smiles: c1cc(c2=cc=cc=c2c1)c3=nccn3.. "
"cough and cold and antiallergy products. this classification denotes agents that are used to treat the common cold and similar such maladies. these might treat allergic reactions, decongest, suppress cough, or render coughs more productive. of the allergy-oriented medications, most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells.. sequifenadine. this classification denotes a serotonin antagonist and histamine-1 receptor antagonist with the molecular formula c22h27no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier c7q3tbr3fp, chemically known as 3-quinuclidinemethanol, alpha,alpha-di-o-tolyl- but more generally known as sequifenadine, which bears u.s. nih compound identifier 42553. european medicines agency schedules sequifenadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10488mig. the term sequifenadine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 1, no. 4, 1987, list 27). sequifenadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. . "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. amobarbital/ephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. albuterol/ipratropium. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/ammonium chloride/diphenhydramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/ephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/ephedrine/guaifenesin/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/ephedrine/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/ephedrine/phenobarbital/potassium iodide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/guaifenesin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. aminophylline/potassium iodide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/guaifenesin/phenobarbital/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. budesonide/formoterol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. butabarbital/ephedrine/guaifenesin/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. butabarbital/epinephrine/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. butabarbital/guaifenesin/pseudoephedrine/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. calcium iodide/isoproterenol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. chlorpheniramine/ephedrine/guaifenesin/phenobarbital/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. dextromethorphan/dyphylline/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. dyphylline/ephedrine/guaifenesin/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. dyphylline/guaifenesin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. formoterol/mometasone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/guaifenesin/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/hydroxyzine/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/isoproterenol/phenobarbital/potassium/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/phenobarbital/potassium iodide/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/phenobarbital/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/secobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. fluticasone/salmeterol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. glycerol, iodinated/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. guaifenesin/oxtriphylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. guaifenesin/sodium citrate/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. guaifenesin/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. phenobarbital/potassium iodide/sodium bicarbonate/theobromine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. potassium iodide/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re109. this va drug class (re109) classifies this compound as belonging to the group antiasthma, other.. "
"combination antiasthma agents. this classification denotes combination drugs that treat a bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea. typical combination antiasthma agent constituents are albuterol, aminophylline, dyphylline, ephedrine, fluticasone, and formoterol.. ephedrine hydrochloride + guaiacol + sulfoguayacol. antiasthmatic and expectorant. "
"combination antituberculars. this classification denotes combination drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. typical combination antitubercular constituents are isoniazid, pyrazinamide, pyridoxine, and rifampin.. . "
"combination antituberculars. this classification denotes combination drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. typical combination antitubercular constituents are isoniazid, pyrazinamide, pyridoxine, and rifampin.. isoniazid/pyrazinamide/rifampin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am500. this va drug class (am500) classifies this compound as belonging to the group antituberculars.. "
"combination antituberculars. this classification denotes combination drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. typical combination antitubercular constituents are isoniazid, pyrazinamide, pyridoxine, and rifampin.. isoniazid/pyridoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am500. this va drug class (am500) classifies this compound as belonging to the group antituberculars.. "
"combination antituberculars. this classification denotes combination drugs used in the treatment of tuberculosis, any of the infectious diseases of man and other animals caused by species of mycobacterium. such drugs are divided into two main classes: first-line agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and second-line drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. typical combination antitubercular constituents are isoniazid, pyrazinamide, pyridoxine, and rifampin.. isoniazid/rifampin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class am500. this va drug class (am500) classifies this compound as belonging to the group antituberculars.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. . "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. ephedrine/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re102. this va drug class (re102) classifies this compound as belonging to the group bronchodilators, sympathomimetic, inhalation.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. acetaminophen/caffeine/phenylpropanolamine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re900. this va drug class (re900) classifies this compound as belonging to the group respiratory agents, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula c8h10n4o2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3g6a5w338e, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears u.s. national institutes of health compound identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. the european medicines agency schedules caffeine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13146mig. the third component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h23n3o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier hpe317o9tl, chemically known as n,n-dimethyl-n-(p-methoxybenzyl)-n-(2-pyridyl)ethylenediamine but more generally known as pyrilamine, which bears u.s. national institutes of health compound identifier 4992.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. acetaminophen/diphenhydramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 8gts82s83m, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but more generally known as diphenhydramine, which bears u.s. national institutes of health compound identifier 3100. the european medicines agency schedules diphenhydramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07211mig. the term diphenhydramine is an international non-proprietary name. the world health organization schedules diphenhydramine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. aminophylline/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re104. this va drug class (re104) classifies this compound as belonging to the group bronchodilators, xanthine-derivative.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. camphor/eucalyptus oil/menthol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re900. this va drug class (re900) classifies this compound as belonging to the group respiratory agents, other.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. camphor/eucalyptus oil/menthol/turpentine spirits. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re900. this va drug class (re900) classifies this compound as belonging to the group respiratory agents, other.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. cetyl alcohol/colfosceril palmitate/tyloxapol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re900. this va drug class (re900) classifies this compound as belonging to the group respiratory agents, other.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. chlorpheniramine/methscopolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re105. this va drug class (re105) classifies this compound as belonging to the group bronchodilators, anticholinergic.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. dextrose/theophylline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re104. this va drug class (re104) classifies this compound as belonging to the group bronchodilators, xanthine-derivative.. "
"combination bronchodilators and respiratory agents. this classification denotes a) combination drugs that cause an increase in the expansion of a bronchus or bronchial tubes, hence the term bronchodilators; b) that treat disorders of the tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about, or the respiratory system, hence the term respiratory agents. typical combination bronchodilator and respiratory agent constituents are acetaminophen, aminophylline, camphor, cetyl alcohol, chlorpheniramine, dextrose, ephedrine, and isoproterenol.. isoproterenol/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re102. this va drug class (re102) classifies this compound as belonging to the group bronchodilators, sympathomimetic, inhalation.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. . "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine/phenylephrine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (n maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h23n3o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier hpe317o9tl, chemically known as n,n-dimethyl-n-(p-methoxybenzyl)-n-(2-pyridyl)ethylenediamine but more generally known as pyrilamine, which bears u.s. national institutes of health compound identifier 4992.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/aluminum acetate/chlorpheniramine/phenylpropanolam. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an astringent, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 80ehd8i43d. the european medicines agency schedules aluminium acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12809mig. aluminum acetate generally arises in the molecular formula 3c2h3o2.al. the term aluminum acetate is a u.s. pharmacopeial convention designation. the third component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (in maleate form, the most common form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine generally arises in the molecular formula c16h19cln2. the term chlorpheniramine is a european pharmacopoeia designation. the fourth component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/aspirin/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a cyclooxygenase inhibitor with the molecular formula c9h8o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier r16co5y76e, chemically known as salicylic acid, acetyl- but more generally known as acetylsalicylic acid, which bears u.s. national institutes of health compound identifier 2244. the european medicines agency schedules acetylsalicylic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12730mig. the world health organization schedules acetylsalicylic acid in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/brompheniramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c16h19brn2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier h57g17p2fn, chemically known as 3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but more generally known as brompheniramine, which bears u.s. national institutes of health compound identifier 6834. brompheniramine most often comes in base and maleate forms. the european medicines agency schedules brompheniramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05924mig. the term brompheniramine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). the world health organization schedules brompheniramine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/caffeine/chlorpheniramine/phenylephrine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula c8h10n4o2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3g6a5w338e, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears u.s. national institutes of health compound identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. the european medicines agency schedules caffeine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13146mig. the world health organization schedules caffeine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (under maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine generally arises in the molecular formula c16h19cln2. the term chlorpheniramine maleate is a european pharmacopoeia designation. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification. the fifth component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h23n3o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier hpe317o9tl, chemically known as n,n-dimethyl-n-(p-methoxybenzyl)-n-(2-pyridyl)ethylenediamine but more generally known as pyrilamine, which bears u.s. national institutes of health compound identifier 4992.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/caffeine/chlorpheniramine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula c8h10n4o2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3g6a5w338e, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears u.s. national institutes of health compound identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. the european medicines agency schedules caffeine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13146mig. the world health organization schedules caffeine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (under maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine generally arises in the molecular formula c16h19cln2. the term chlorpheniramine maleate is a european pharmacopoeia designation. the fourth componeny of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/caffeine/guaifenesin/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula c8h10n4o2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3g6a5w338e, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears u.s. national institutes of health compound identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. the european medicines agency schedules caffeine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13146mig. the third component of this combination drug is an expectorant with the molecular formula c10h14o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 495w7451vq, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears u.s. national institutes of health compound identifier 3516. the european medicines agency schedules guaifenesin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07973mig. the term guaifenesin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). the world health organization schedules guaifenesin in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/caffeine/phenylpropanolamine/salicylamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula c8h10n4o2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3g6a5w338e, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears u.s. national institutes of health compound identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. the european medicines agency schedules caffeine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13146mig. the third component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is a nonsteroidal antiinflammatory drug, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier em8bm710zc. the european medicines agency schedules salicylamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10426mig. salicylamide generally arises in the molecular formula c7h7no2. the term salicylamide is an international non-proprietary name or inn.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (n maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine/phenylephrine/salicylamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (n maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is a nonsteroidal antiinflammatory drug, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier em8bm710zc. the european medicines agency schedules salicylamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10426mig. salicylamide generally arises in the molecular formula c7h7no2. the term salicylamide is an international non-proprietary name or inn.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (in maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine/phenylpropanolamine/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (in maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification. the fourth compone of this combination druug is a histamine-1 receptor antagonist with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier k65lb6598j, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-tolyloxy)ethylamine but more generally known as phenyltoloxamine, which bears u.s. national institutes of health compound identifier 7077. the european medicines agency schedules phenyltoloxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09791mig. the term phenyltoloxamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3).. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine/phenylpropanolamine/salicylamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (in maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification. the forth component of this combination drug is a nonsteroidal antiinflammatory drug, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier em8bm710zc. the european medicines agency schedules salicylamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10426mig. salicylamide generally arises in the molecular formula c7h7no2. the term salicylamide is an international non-proprietary name or inn.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/chlorpheniramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (in maleate form) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/dexbrompheniramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re515. this va drug class (re515) classifies this compound as belonging to the group decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c16h19brn2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 75t64b71rp, chemically known as 3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-yl-propan-1-amine but more generally known as dexbrompheniramine, which bears u.s. national institutes of health compound identifier 16960. the european medicines agency schedules dexbrompheniramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07021mig. the world health organization schedules dexbrompheniramine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/dextromethorphan/guaifenesin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an expectorant with the molecular formula c10h14o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 495w7451vq, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears u.s. national institutes of health compound identifier 3516. the european medicines agency schedules guaifenesin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07973mig. the term guaifenesin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). the world health organization schedules guaifenesin in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/diphenhydramine/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 8gts82s83m, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but more generally known as diphenhydramine, which bears u.s. national institutes of health compound identifier 3100. the european medicines agency schedules diphenhydramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07211mig. the term diphenhydramine is an international non-proprietary name. the world health organization schedules diphenhydramine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. ammonium/antimony/chlorpheniramine/potassium guaiacolsulfonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/phenylpropanolamine/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier k65lb6598j, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-tolyloxy)ethylamine but more generally known as phenyltoloxamine, which bears u.s. national institutes of health compound identifier 7077. the european medicines agency schedules phenyltoloxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09791mig. the term phenyltoloxamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3).. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier k65lb6598j, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-tolyloxy)ethylamine but more generally known as phenyltoloxamine, which bears u.s. national institutes of health compound identifier 7077. the european medicines agency schedules phenyltoloxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09791mig. the term phenyltoloxamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3).. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/phenyltoloxamine/salicylamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier k65lb6598j, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-tolyloxy)ethylamine but more generally known as phenyltoloxamine, which bears u.s. national institutes of health compound identifier 7077. the european medicines agency schedules phenyltoloxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09791mig. the term phenyltoloxamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). the third component of this combination drug is a nonsteroidal antiinflammatory drug, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier em8bm710zc. the european medicines agency schedules salicylamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10426mig. salicylamide generally arises in the molecular formula c7h7no2. the term salicylamide is an international non-proprietary name or inn.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. acetaminophen/pseudoephedrine/triprolidine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 2l8t9s52qm. the european medicines agency schedules triprolidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11323mig. triprolidine generally arises in the molecular formula c19h22n2. the term triprolidine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3.). "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. ammonium chloride/diphenhydramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. ammonium chloride/diphenhydramine/menthol/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. ammonium chloride/glycyrrhiza/hyoscyamus/phenobarbital/terpin hydrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. atropine/chlorpheniramine/hyoscyamine/phenylephrine/scopolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. aspirin/caffeine/chlorpheniramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. aspirin/chlorpheniramine/phenylpropanolamine/sodium acetylsalicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. aspirin/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. aspirin/phenypropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. aspirin/promethazine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. aspirin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. atropine/brompheniramine/phenyltoloxamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. atropine/chlorpheniramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. atropine/chlorpheniramine/ephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. chlorpheniramine/methscopolamine/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re500. this va drug class (re500) classifies this compound as belonging to the group cold remedies, combinations.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. atropine/chlorpheniramine/phenylephrine/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. atropine/chlorpheniramine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. belladonna/chlorpheniramine/ephedrine/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. belladonna/chlorpheniramine/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. belladonna/chlorpheniramine/phenylephrine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. benzocaine/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. caffeine/pheniramine/phenylephrine/sodium citrate/sodium salicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. calcium lactate/guaifenesin/hyoscyamus/phenobarbital/terpin hydrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. caramiphen/chlorpheniramine/isopropamide/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. potassium guaiacolsulfonate/promethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. chlorpheniramine/methscopolamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. diphenhydramine/guaifenesin/menthol/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. ibuprofen/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. magnesium salicylate/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. methscopolamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination cold remedies. this classification denotes combination drugs and preparations that alleviate symptons of and treat a catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. it generally involves a runny nose, nasal congestion, and sneezing, called the common cold, hence the term cold remedies. typical combination cold remedy constituents are acetaminophen, ammonium, ammonium chloride, aspirin, atropine, belladonna, benzocaine, caffeine, calcium lactate, caramiphen, chlorpheniramine, citric, diphenhydramine, ibuprofen, magnesium salicylate, methscopolamine, naproxen, and potassium guaiacolsulfonate.. naproxen/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re599. this va drug class (re599) classifies this compound as belonging to the group cold remedies, other.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. . "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. dextromethorphan/guaifenesin/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re513. this va drug class (re513) classifies this compound as belonging to the group decongestant/antitussive/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. acetaminophen/dextromethorphan/guaifenesin/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re514. this va drug class (re514) classifies this compound as belonging to the group decongestant/antitussive/expectorant/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an expectorant with the molecular formula c10h14o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 495w7451vq, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears u.s. national institutes of health compound identifier 3516. the european medicines agency schedules guaifenesin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07973mig. the term guaifenesin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). the world health organization schedules guaifenesin in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. acetaminophen/dextromethorphan/guaifenesin/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re514. this va drug class (re514) classifies this compound as belonging to the group decongestant/antitussive/expectorant/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an expectorant with the molecular formula c10h14o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 495w7451vq, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears u.s. national institutes of health compound identifier 3516. the european medicines agency schedules guaifenesin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07973mig. the term guaifenesin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). the world health organization schedules guaifenesin in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. acetaminophen/dextromethorphan/guaifenesin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re514. this va drug class (re514) classifies this compound as belonging to the group decongestant/antitussive/expectorant/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an expectorant with the molecular formula c10h14o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 495w7451vq, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears u.s. national institutes of health compound identifier 3516. the european medicines agency schedules guaifenesin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07973mig. the term guaifenesin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). the world health organization schedules guaifenesin in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. acetaminophen/dextromethorphan/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re515. this va drug class (re515) classifies this compound as belonging to the group decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. acetaminophen/dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re515. this va drug class (re515) classifies this compound as belonging to the group decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. caramiphen/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re512. this va drug class (re512) classifies this compound as belonging to the group decongestant/antitussive.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. dextromethorphan/guaifenesin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. dextromethorphan/guaifenesin/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re513. this va drug class (re513) classifies this compound as belonging to the group decongestant/antitussive/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. dextromethorphan/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re512. this va drug class (re512) classifies this compound as belonging to the group decongestant/antitussive.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. dextromethorphan/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re512. this va drug class (re512) classifies this compound as belonging to the group decongestant/antitussive.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re512. this va drug class (re512) classifies this compound as belonging to the group decongestant/antitussive.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. ephedrine/guaifenesin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re516. this va drug class (re516) classifies this compound as belonging to the group decongestant/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. ephedrine/potassium iodide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re516. this va drug class (re516) classifies this compound as belonging to the group decongestant/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. guaifenesin/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re516. this va drug class (re516) classifies this compound as belonging to the group decongestant/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. guaifenesin/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re516. this va drug class (re516) classifies this compound as belonging to the group decongestant/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. guaifenesin/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re516. this va drug class (re516) classifies this compound as belonging to the group decongestant/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. guaifenesin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re516. this va drug class (re516) classifies this compound as belonging to the group decongestant/expectorant.. "
"combination decongestants, with analgesics, antitussives, or expectorants. this classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term decongestants; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.. phenylephrine/phenylpropanolamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re200. this va drug class (re200) classifies this compound as belonging to the group decongestants, systemic.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. . "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. acetaminophen/dextromethorphan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. ammonium chloride/antimony potassium tartrate/ipecac. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. ammonium chloride/antimony/guaiacolsulfonate/potassium tartrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. ammonium chloride/ipecac. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. ammonium chloride/ipecac/tolu balsam. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. ammonium chloride/potassium guaiacolsulfonate/terpin hydrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. benzocaine/dextromethorphan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. calcium creosotate/iodine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. carbetapentane/guaifenesin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. dextromethorphan/glycerol, iodinated. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination non-opioid-containing antitussives/expectorants. this classification denotes combination drugs and preparations that do not bind to opioid receptors, which do not derive from opium or morphine, which are non-addictive, and which are not narcotics, that a) suppress cough, hence the term antitussives; and/or b) increase mucous excretion, hence the term expectorants. these drugs therefore bear the names non-opioid-containing antitussives and non-opioid-containing expectorants. typical combination non-opioid-containing antitussive/expectorant constituents are antimony, antimony potassium tartrate, dextromethorphan, glycerol, iodinated, guaifenesin, iodine, ipecac, potassium guaiacolsulfonate, potassium iodide, and terpin hydrate.. dextromethorphan/terpin hydrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. . "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. alloclamide. this classification denotes an antitussive agent with the molecular formula c16h23cln2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) h7b263z7aq, chemically known as benzamide, 4-chloro-n-(2-(diethylamino)ethyl)-2-(2-propenyloxy)- (9ci) but more generally known as alloclamide, which bears us nih compound identifier 71837. alloclamide comes in forms base and hydrochloride. european medicines agency schedules alloclamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05335mig. the term alloclamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). alloclamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule alloclamide under hs 29242995 and sitc 51479. as of q4 2014, alloclamide remains us fdas preferred term for this commodity. alloclamide bears us nlm identifiers umls id c0051206 and nci concept code c73184. smiles: clc1cc(occ=c)c(c(=o)nccn(cc)cc)cc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. bibenzonium. this classification denotes an antitussive agent with the molecular structure c19h26no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 34ytz517s2 chemically known as (2-(1,2-diphenylethoxy)ethyltrimethyl)ammonium, but more commonly known as bibenzonium, which bears us nih compound identifier 71954. european medicines agency schedules bibenzonium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00798mig. as of q4 2014, bibenzonium remains us fdas preferred term for this commodity. bibenzonium bears us nlm identifiers umls id c2347006 and nci concept code c73821. smiles: o(cc[n](c)(c)c)c(cc1ccccc1)c1ccccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. benzonatate. this classification denotes an antitussive agent with the molecular formula c12h17no2(c2h4o)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 5p4dhs6enr, chemically known as 2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl p-(butylamino)benzoate but more generally known as benzonatate, which bears us nih compound identifier 7699. european medicines agency schedules benzonatate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05760mig. the term benzonatate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules benzonatate in its anatomical therapeutic chemical (atc) classification. benzonatate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule benzonatate under hs 34021300 and sitc 55421. as of q4 2014, benzonatate remains us fdas preferred term for this commodity. benzonatate bears us nlm identifiers umls id c0053229 and nci concept code c28863. smiles: ccccnc1=cc=c(c=c1)c(=o)occoccoccoccoccoccoccoccoccoc.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. benproperine. this classification denotes an antitussive agent with the molecular formula c21h27no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 3aa6iz48yk, chemically known as piperidine, 1-(1-methyl-2-((alpha-phenyl-o-tolyl)oxy)ethyl)- but more generally known as benproperine, which bears us nih compound identifier 2326. benproperine most often comes in basem, embonate, pamoate, phosphate, and trihydrogen phosphate forms. european medicines agency schedules benproperine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05728mig. the term benproperine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules benproperine in its anatomical therapeutic chemical (atc) classification. benproperine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule benproperine under hs 29333999 and sitc 51574. as of q4 2014, benproperine remains us fdas preferred term for this commodity. benproperine bears us nlm identifiers umls id c0772056 and nci concept code c78103. smiles: o(cc(n1ccccc1)c)c1c(cc2ccccc2)cccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. benproperine embonate. this classification denotes an antitussive agent with the molecular formula c23h16o6.2c21h27no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 370c8cb2k3, chemically known as piperidine, 1-(1-methyl-2-(2-(phenylmethyl)phenoxy)ethyl)-, 4,4-methylenebis(3-hydroxy-2-naphthalenecarboxylate) (2:1), but more generally known as benproperine embonate, which bears us nih compound identifier 11979739. european medicines agency schedules benproperine embonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05728mig. most nations, for tariff purposes, schedule benproperine embonate under hs 29333999. smiles: cc(coc1ccccc1cc2ccccc2)n3ccccc3.cc(coc1ccccc1cc2ccccc2)n3ccccc3.c1ccc2c(c1)cc(c(c2cc3c4ccccc4cc(c3o)c(=o)o)o)c(=o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. benproperine pamoate. this classification denotes an antitussive agent with the molecular formula c23h16o6.2c21h27no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 370c8cb2k3. most nations, for tariff and trade purposes, schedule benproperine pamoate under hs 29333999. as of q4 2014, benproperine pamoate remains us fdas preferred term for this commodity. smiles: cc(coc1ccccc1cc2ccccc2)n3ccccc3.cc(coc1ccccc1cc2ccccc2)n3ccccc3.c1ccc2c(c1)cc(c(c2cc3c4ccccc4cc(c3o)c(=o)o)o)c(=o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. amicibone. this classification denotes an antitussive agent with the molecular formula c22h31no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 741zw9md1g, chemically known as 1-(2-(1h-azepin-1-yl)ethyl)-2-oxocyclohexane carboxylic acid, benzyl ester but more generally known as amicibone, which bears us nih compound identifier 31793. european medicines agency schedules amicibone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05423mig. the term amicibone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). amicibone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule amicibone under hs 29339990 and sitc 51577. as of q4 2014, amicibone remains us fdas preferred term for this commodity. amicibone bears us nlm identifiers umls id c2983871 and nci concept code c90773. smiles: o(c(=o)c1(ccn2cccccc2)ccccc1=o)cc1ccccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. benproperine phosphate. this classification denotes an antitussive agent with the molecular formula c21h27no.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s831z48c5w, chemically known as piperidine, 1-(1-methyl-2-((alpha-phenyl-o-tolyl)oxy)ethyl)-, phosphate but more generally known as benproperine phosphate, which bears us nih compound identifier 167811. european medicines agency schedules benproperine phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00705mig. most nations, for tariff and trade purposes, schedule benproperine phosphate under hs 29333999 and sitc 51574. as of q4 2014, benproperine phosphate remains us fdas preferred term for this commodity. smiles: cc(coc1ccccc1cc2ccccc2)n3ccccc3.op(=o)(o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. benproperine trihydrogen phosphate. this classification denotes an antitussive agent with the molecular formula c21h27no.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s831z48c5w, chemically known as 1-(2-(2-benzylphenoxy)-1-methylethyl)piperidine monophosphate, but more generally known as benproperine trihydrogen phosphate, which bears us nih compound identifier 167811. european medicines agency schedules benproperine trihydrogen phosphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05728mig. most nations, for tariff purposes, schedule benproperine trihydrogen phosphate under hs 29333999. smiles: cc(coc1ccccc1cc2ccccc2)n3ccccc3.op(=o)(o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. bibenzonium bromide. this classification denotes an antitussive agent with the molecular formula c19h26no.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4455j9277q, chemically known as (2-(1,2-diphenylethoxy)ethyltrimethyl)ammonium bromide but more generally known as bibenzonium bromide, which bears us nih compound identifier 85001. european medicines agency schedules bibenzonium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05815mig. the term bibenzonium bromide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules bibenzonium bromide in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule bibenzonium bromide under hs 29239000 and sitc 51481. as of q4 2014, bibenzonium bromide remains us fdas preferred term for this commodity. bibenzonium bromide bears us nlm identifiers umls id c2347007 and nci concept code c73180. smiles: c[n+](c)(c)ccoc(cc1ccccc1)c2ccccc2.[br-].. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. butamirate. this classification denotes an antitussive agent with the molecular formula c18h29no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) m75mzg2236, chemically known as butyric acid, 2-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate but more generally known as butamirate, which bears us nih compound identifier 28891. butamirate most often comes in base and citrate forms. european medicines agency schedules butamirate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06000mig. the term butamirate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules butamirate in its anatomical therapeutic chemical (atc) classification. butamirate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule butamirate under hs 29221980 and sitc 51461. as of q4 2014, butamirate remains us fdas preferred term for this commodity. butamirate bears us nlm identifiers umls id c0054236 and nci concept code c81596. smiles: o(ccn(cc)cc)ccoc(=o)c(cc)c1ccccc1.oc(cc(=o)o)(cc(=o)o)c(=o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. carbetapentane. this classification denotes a cyclopentane and antitussive agent with the molecular formula c20h31no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 32c726x12w, chemically known as 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentane-1-carboxylate; 2-hydroxypropane-1,2,3-tricarboxylic acid but more generally known as pentoxyverine, which bears us nih compound identifier 2562. european medicines agency schedules pentoxyverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09706mig. world health organization schedules pentoxyverine in its anatomical therapeutic chemical (atc) classification. pentoxyverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ccn(cc)ccoccoc(=o)c1(cccc1)c2=cc=cc=c2.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. butamirate citrate. this classification denotes an antitussive agent with the molecular formula c18h29no3.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 67hp51l98r, chemically known as butyric acid, 2-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate but more generally known as butamirate citrate, which bears us nih compound identifier 28891. european medicines agency schedules butamirate citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00911mig. most nations, for tariff and trade purposes, schedule butamirate citrate under hs 29221980 and sitc 51461. as of q4 2014, butamirate citrate remains us fdas preferred term for this commodity. smiles: ccc(c1ccccc1)c(=o)occoccn(cc)cc.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. caramiphen. this classification denotes an antitussive agent with the molecular formula c18h27no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 97j7np0xjy, chemically known as cyclopentanecarboxylic acid, 1-phenyl-, 2-(diethylamino)ethyl ester but more generally known as caramiphen, which bears us nih compound identifier 6472. caramiphen most often comes in base, ethanedisulfonate, hydrochloride, and hydrogen edisilate. european medicines agency schedules caramiphen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06085mig. the term caramiphen is an international non-proprietary name. caramiphen is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule caramiphen under hs 29221980 and sitc 51461. as of q4 2014, caramiphen remains us fdas preferred term for this commodity. caramiphen bears us nlm identifiers umls id c0054635 and nci concept code c81594. smiles: o(c(=o)c1(cccc1)c1ccccc1)ccn(cc)cc.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. clobutinol. this classification denotes an antitussive agent with the molecular formula c14h22clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 1ny2ix043a, chemically known as 1-(4-chlorophenyl)-2,3-dimethyl-4-dimethylamino-2-butanol but more generally known as clobutinol, which bears us nih compound identifier 26937. european medicines agency schedules clobutinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06680mig. the term clobutinol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules clobutinol in its anatomical therapeutic chemical (atc) classification. clobutinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule clobutinol under hs 29221980 and sitc 51461. as of q4 2014, clobutinol remains us fdas preferred term for this commodity. clobutinol bears us nlm identifiers umls id c0055897 and nci concept code c78105. smiles: clc1ccc(cc(o)(c(cn(c)c)c)c)cc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. chlophedianol or clofedanol. this classification denotes an anticholinergic agent with the molecular formula c17h20clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42c50p12ap, chemically known as benzhydrol, 2-chloro-alpha-(2-(dimethylamino)ethyl)- but more generally known as chlophedianol, which bears us nih compound identifier 2795. european medicines agency schedules clofedanol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06695mig. the term clofedanol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules chlophedianol in its anatomical therapeutic chemical (atc) classification. chlophedianol or clofedanol bears us nlm identifiers umls id c0055904 and nci concept code c73183. smiles: clc1c(c(o)(ccn(c)c)c2ccccc2)cccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. cloperastine. this classification denotes an antitussive agent with the molecular formula c20h24clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 69m5l7bxek, chemically known as piperidine, 1-(2-((p-chloro-alpha-phenylbenzyl)oxy)ethyl)- but more generally known as cloperastine, which bears us nih compound identifier 2805. european medicines agency schedules cloperastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06737mig. the term cloperastine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules cloperastine in its anatomical therapeutic chemical (atc) classification. cloperastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cloperastine under hs 29333999 and sitc 51574. as of q4 2014, cloperastine remains us fdas preferred term for this commodity. cloperastine bears us nlm identifiers umls id c0055930 and nci concept code c78106. smiles: clc1ccc(c(occn2ccccc2)c2ccccc2)cc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. cloperastine fendizoate. this classification denotes an antitussive agent c20h24clno.c20h14o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2m105305su, chemically known as benzoic acid, 2-((6-hydroxy(1,1-biphenyl)-3-yl)carbonyl)-, compd. with 1-(2-((4-chlorophenyl)phenylmethoxy)ethyl)piperidine (1:1), but more generally known as cloperastine fendizoate, which bears us nih compound identifier 163446. european medicines agency schedules cloperastine fendizoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01366mig. most nations, for tariff and trade purposes, schedule cloperastine fendizoate under hs 29333999 and sitc 51574. as of q4 2014, cloperastine fendizoate remains us fdas preferred term for this commodity. cloperastine fendizoate bears us nlm identifiers umls id c2987012 and nci concept code c95234. smiles: c1ccc(cc1)c2c(cccc2o)c(=o)c3ccccc3c(=o)o.c1ccc(cc1)c(c2ccc(cc2)cl)occn3ccccc3.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. cyclexanone. this classification denotes an antitussive agent with the molecular formula c16h25no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 2ou4ks37eo, chemically known as 4(5h)-oxazolone, 2-(cyclopropylamino)-5-phenyl- (9ci) but more generally known as cyclexanone, which bears us nih compound identifier 26701. european medicines agency schedules cyclexanone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06845mig. the term cyclexanone is an international non-proprietary name. cyclexanone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cyclexanone under hs 29349990 and sitc 51579. as of q4 2014, cyclexanone remains us fdas preferred term for this commodity. cyclexanone bears us nlm identifiers umls id c2699484 and nci concept code c78108. smiles: o1c(=nc(=o)c1c1ccccc1)nc1cc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. dimethoxanate. this classification denotes an antitussive agent with the molecular formula c19h22n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 1e3kg5fwdb, chemically known as 10h-phenothiazine-10-carboxylic acid, 2-(2-(dimethylamino)ethoxy)ethyl ester but more generally known as dimethoxanate, which bears us nih compound identifier 10610. european medicines agency schedules dimethoxanate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07175mig. the term dimethoxanate is an international non-proprietary name. world health organization schedules dimethoxanate in its anatomical therapeutic chemical (atc) classification. dimethoxanate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule dimethoxanate under hs 29343090 and sitc 51578. as of q4 2014, dimethoxanate remains us fdas preferred term for this commodity. dimethoxanate bears us nlm identifiers umls id c0392426 and nci concept code c80896. smiles: s1c2c(n(c3c1cccc3)c(=o)occoccn(c)c)cccc2.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. dipropizine or dropropizine. this classification denotes an antispasmotic agent with the molecular formula c13h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u0k8whl37u, chemically known as 1,2-propanediol, 3-(4-phenyl-1-piperazinyl)-, (r,s)- but more generally known as dropropizine, which bears us nih compound identifier 3169. european medicines agency schedules dropropizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06412mig. the term dropropizine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules dropropizine in its anatomical therapeutic chemical (atc) classification. dropropizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. dipropizine or dropropizine bears us nlm identifiers umls id c0058425 and nci concept code c73179. smiles: oc(cn1ccn(cc1)c1ccccc1)co.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. fedrilate. this classification denotes an antitussive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) nt86r8m7j5. european medicines agency schedules fedrilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07525mig. fedrilate generally arises in the molecular formula c20h29no4. the term fedrilate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9.) fedrilate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fedrilate under hs 29349990 and sitc 51579. as of q4 2014, fedrilate remains us fdas preferred term for this commodity. fedrilate bears us nlm identifiers umls id c0771169 and nci concept code c81597. smiles: o1ccc(cc1)(c1ccccc1)c(=o)oc(ccn1ccocc1)c.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. dibunate. this classification denotes a cough suppressant with the molecular formula c18h24o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zxy319vl5s, chemically known as 1-naphthalenesulfonic acid, 3,6-bis(1,1-dimethylethyl)-, ethyl ester or 2,6-ditert-butylnaphthalene-1-sulfonic acid but more generally known as dibunate, which bears us nih compound identifier 3084737. european medicines agency schedules dibunate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10557mig. the term dibunate is an international non-proprietary name or inn. as of q4 2014, dibunate remains us fdas preferred term for this commodity. smiles: cc(c)(c)c1=cc2=c(c=c1)c(=c(c=c2)c(c)(c)c)s(=o)(=o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. dimemorfan. this classification denotes an antitussive agent and anticonvulsant agent with the molecular formula c18h25n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 623oac38yu, chemically known as morphinan, 3,17-dimethyl-, (9alpha,13alpha,14alpha)- but more generally known as dimemorfan, which bears us nih compound identifier 3037918. european medicines agency schedules dimemorfan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07158mig. the term dimemorfan is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21, no. 3, 2007, list 58). world health organization schedules dimemorfan in its anatomical therapeutic chemical (atc) classification. dimemorfan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule dimemorfan under hs 29334990 and sitc 51575. as of q4 2014, dimemorfan remains us fdas preferred term for this commodity. dimemorfan bears us nlm identifiers umls id c0058193 and nci concept code c65399. smiles: n1(c2c3c(cc1)(cccc3)c1c(c2)ccc(c1)c)c.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. droxypropine. this classification denotes an antitussive agent and analgesic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 94j1smk20x. european medicines agency schedules droxypropine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06422mig. droxypropine generally arises in the molecular formula c18h27no3. the term droxypropine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5.) droxypropine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule droxypropine under hs 29333999 and sitc 51574. as of q4 2014, droxypropine remains us fdas preferred term for this commodity. droxypropine bears us nlm identifiers umls id c1880419 and nci concept code c65493. smiles: o=c(c1(ccn(cc1)ccocco)c1ccccc1)cc.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. dextromethorphan. this classification denotes an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears us nih compound identifier 3008. european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. dextromethorphan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule dextromethorphan under hs 29334930 and sitc 51575. as of q4 2014, dextromethorphan remains us fdas preferred term for this commodity. dextromethorphan bears us nlm identifiers umls id c0011816 and nci concept code c62022. smiles: o(c1cc2c34c(c(n(cc3)c)cc2cc1)cccc4)c.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. dimemorfan phosphate. this classification denotes an antitussive agent and anticonvulsant agent with the molecular formula c18h25n.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s203y5y1qp, chemically known as 3,17-dimethyl-9-alpha,13-alpha,14-alpha-morphinan phosphate but more generally known as dimemorfan phosphate, which bears us nih compound identifier 5492722. european medicines agency schedules dimemorfan phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01739mig. most nations, for tariff and trade purposes, schedule dimemorfan phosphate under hs 29334990 and sitc 51575. as of q4 2014, dimemorfan phosphate remains us fdas preferred term for this commodity. smiles: cc1ccc2c(c1)[c@]34cccc[c@@h]3[c@h](c2)n(cc4)c.op(=o)(o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. fedrilate maleate. this classification denotes an antitussive agent c20h29no4.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7uf5m66eur, chemically known as 2h-pyran-4-carboxylic acid, tetrahydro-4-phenyl-, 1-methyl-3-(4-morpholinyl)propyl ester, (2z)-2-butenedioate (1:1), but more generally known as fedrilate maleate, which bears us nih compound identifier 71587508. european medicines agency schedules fedrilate maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02105mig. most nations, for tariff and trade purposes, schedule fedrilate maleate under hs 29349990 and sitc 51579. as of q4 2014, fedrilate maleate remains us fdas preferred term for this commodity. smiles: cc(ccn1ccocc1)oc(=o)c2(ccocc2)c3ccccc3.c(=c\\c(=o)o)\\c(=o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. levopropoxyphene. this classification denotes an antitussive agent with the molecular formula c22h29no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) u75vz9pk1j, chemically known as [(2r,3s)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate, but more generally know as levopropoxyphene, which bears us nih compound identifier 200742. the term levopropoxyphene is an international non-proprietary name or inn. most nations, for tariff and trade purposes, schedule levopropoxyphene under hs 29221980 and sitc 51461. as of q4 2014, levopropoxyphene remains us fdas preferred term for this commodity. smiles: ccc(=o)oc(cc1=cc=cc=c1)(c2=cc=cc=c2)c(c)cn(c)c.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. meprotixol. this classification denotes an antitussive agent with the molecular formula c19h23no2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 2jxz154z0q, chemically known as 9h-thioxanthen-9-ol, 9-(3-(dimethylamino)propyl)-2-methoxy- but more generally known as meprotixol, which bears us nih compound identifier 71195. european medicines agency schedules meprotixol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08759mig. the term meprotixol is an international non-proprietary name. world health organization schedules meprotixol in its anatomical therapeutic chemical (atc) classification. meprotixol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule meprotixol under hs 29349990 and sitc 51579. as of q4 2014, meprotixol remains us fdas preferred term for this commodity. meprotixol bears us nlm identifiers umls id c2981321 and nci concept code c87660. smiles: s1c2c(c(o)(cccn(c)c)c3c1cccc3)cc(oc)cc2.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. levopropoxyphene napsilate or levopropoxyphene napsylate. this classification denotes an antitussive agent with the molecular formula c22h29no2.c10h8o3s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kk9590r73s, chemically known as benzeneethanol, .alpha.-(2-(dimethylamino)-1-methylethyl)-.alpha.-phenyl-, propanoate (ester), (r-(r*,s*))-, compd. with 2-naphthalenesulfonic acid (1:1), monohydrate, but more generally known as levopropoxyphene napsilate, which bears us nih compound identifier 64736. european medicines agency schedules levopropoxyphene napsilate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08486mig. most nations, for tariff purposes, schedule levopropoxyphene napsilate under hs 29221980. smiles: ccc(=o)o[c@@](cc1ccccc1)(c2ccccc2)[c@@h](c)cn(c)c.c1ccc2cc(ccc2c1)s(=o)(=o)o.o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. isoaminile. this classification denotes an antitussive agent with the molecular formula c16h24n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) r4823w2pql, chemically known as valeronitrile, 4-(dimethylamino)-2-isopropyl-2-phenyl- but more generally known as isoaminile, which bears us nih compound identifier 6481. european medicines agency schedules isoaminile in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08310mig. the term isoaminile is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules isoaminile in its anatomical therapeutic chemical (atc) classification. isoaminile is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule isoaminile under hs 29269095 and sitc 51484. as of q4 2014, isoaminile remains us fdas preferred term for this commodity. isoaminile bears us nlm identifiers umls id c0063912 and nci concept code c83839. smiles: n(c(cc(c(c)c)(c1ccccc1)c#n)c)(c)c.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. levodropropizine. this classification denotes an antitussive agent with the molecular formula c13h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 3o31p6t4g3, chemically known as 1,2-propanediol, 3-(4-phenylpiperazin-1-yl)-, s(-)- but more generally known as levodropropizine, which bears us nih compound identifier 65859. european medicines agency schedules levodropropizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12105mig. the term levodropropizine is an international non-proprietary name. world health organization schedules levodropropizine in its anatomical therapeutic chemical (atc) classification. levodropropizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule levodropropizine under hs 29335995 and sitc 51576. as of q4 2014, levodropropizine remains us fdas preferred term for this commodity. levodropropizine bears us nlm identifiers umls id c0125654 and nci concept code c81593. smiles: oc(cn1ccn(cc1)c1ccccc1)co.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. isoaminile citrate. this classification denotes an antitussive agent with the molecular formula c16h24n2.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 27k34xsd46, chemically known as valeronitrile, 4-(dimethylamino)-2-isopropyl-2-phenyl-, citrate but more generally known as isoaminile citrate, which bears us nih compound identifier 161602. european medicines agency schedules isoaminile citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02783mig. most nations, for tariff and trade purposes, schedule isoaminile citrate under hs 29269095 and sitc 51484. as of q4 2014, isoaminile citrate remains us fdas preferred term for this commodity. smiles: cc(c)c(cc(c)n(c)c)(c#n)c1ccccc1.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. isoaminile cyclamate. this classification denotes an antitussive agent c16h24n2.c6h13no3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4055851484, chemically known as sulfamic acid, n-cyclohexyl-, compd. with .alpha.-(2-(dimethylamino)propyl)-.alpha.-(1-methylethyl)benzeneacetonitrile (1:1), but more generally known as isoaminile cyclamate, which bears us nih compound identifier 112076. most nations, for tariff and trade purposes, schedule isoaminile cyclamate under hs 29269095 and sitc 51484. as of q4 2014, isoaminile cyclamate remains us fdas preferred term for this commodity. smiles: cc(c)c(cc(c)n(c)c)(c#n)c1ccccc1.c1ccc(cc1)ns(=o)(=o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. guaiacolsulfonate or sulfoguaiacolum. this classification denotes an antitussive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 713aj00npg. european medicines agency schedules sulfogaiacol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10740mig. sulfogaiacol generally arises in the molecular formula c7h8o5s.k. the term sulfogaiacol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4.) sulfogaiacol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: c1=cc=c(c(=c1)oco)s(=o)(=o)[o-].[k+].. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. morclofone. this classification denotes an antitussive agent with the molecular formula c21h24clno5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) vy62tib872, chemically known as 4-chloro-3,5-dimethoxy-4-(2-morpholinoethoxy)benzophenone but more generally known as morclofone, which bears us nih compound identifier 35949. european medicines agency schedules morclofone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09065mig. the term morclofone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules morclofone in its anatomical therapeutic chemical (atc) classification. morclofone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule morclofone under hs 29349990 and sitc 51579. as of q4 2014, morclofone remains us fdas preferred term for this commodity. morclofone bears us nlm identifiers umls id c0066796 and nci concept code c66194. smiles: clc1ccc(c(=o)c2cc(oc)c(occn3ccocc3)c(oc)c2)cc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. narcotinum or noscapine. this classification denotes a tubulin binding agent and opioid receptor agonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8v32u4aoqu. european medicines agency schedules noscapine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09383mig. noscapine generally arises in the molecular formula c22h23no7. the term noscapine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 32, no 10 1978, list 18.) noscapine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. narcotinum or noscapine bears us nlm identifiers umls id c0028426 and nci concept code c80589. smiles: o1c(c2n(ccc3c2c(oc)c2ococ2c3)c)c2c(c1=o)c(oc)c(oc)cc2.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. nepinalone. this classification denotes an antitussive agent with the molecular formula c18h25no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) l9806lpr7g, chemically known as (- )-3,4-dihydro-1-methyl-1-(2-piperidinoethyl)-2(1h)-naphthalenone. but more generally known as nepinalone, which bears us nih compound identifier 3047788. european medicines agency schedules nepinalone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09200mig. the term nepinalone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules nepinalone in its anatomical therapeutic chemical (atc) classification. nepinalone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nepinalone under hs 29333999 and sitc 51574. as of q4 2014, nepinalone remains us fdas preferred term for this commodity. nepinalone bears us nlm identifiers umls id c2698448 and nci concept code c76475. smiles: o=c1c(ccn2ccccc2)(c2c(cc1)cccc2)c.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. nonivamide. this classification denotes a capsaicin analog, nitric oxide synthase antagonist and inhibitor, and sensory system agent with the molecular formula c17h27no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) s846b891or, chemically known as nonanamide, n-vanillyl- (8ci) but more generally known as nonivamide, which bears us nih compound identifier 2998. european medicines agency schedules nonivamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09352mig. nonivamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nonivamide under hs 29242995 and sitc 51479. as of q4 2014, nonivamide remains us fdas preferred term for this commodity. smiles: ccccccccc(=o)ncc1=cc(=c(c=c1)o)oc.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. oxeladin. this classification denotes an antitussive agent with the molecular formula c20h33no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) snc1080t5y, chemically known as 2-(2-diethylaminoethoxy)ethyl alpha,alpha-diethylphenylacetate but more generally known as oxeladin, which bears us nih compound identifier 4619. european medicines agency schedules oxeladin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09513mig. world health organization schedules oxeladin in its anatomical therapeutic chemical (atc) classification. oxeladin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule oxeladin under hs 29221980 and sitc 51461. as of q4 2014, oxeladin remains us fdas preferred term for this commodity. smiles: o(c(=o)c(cc)(cc)c1ccccc1)ccoccn(cc)cc.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. oxeladin citrate. this classification denotes an antitussive agent with the molecular formula c20h33no3.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5aev5c340c, chemically known as benzeneacetic acid, .alpha.,.alpha.-diethyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), but more generally known as oxeladin citrate, which bears us nih compound identifier 40384. european medicines agency schedules oxeladin citrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09513mig. most nations, for tariff purposes, schedule oxeladin citrate under hs 29221980. smiles: ccc(cc)(c1ccccc1)c(=o)occoccn(cc)cc.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. nicocodine. this classification denotes an antitussive agent with the molecular formula c24h24n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) dyx391p13e, chemically known as morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 3-pyridinecarboxylate (ester), (5.alpha.,6.alpha.)- but more generally known as nicocodine, which bears us nih compound identifier 520825. european medicines agency schedules nicocodine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09233mig. the term nicocodine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). nicocodine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nicocodine under hs 29391900 and sitc 54141. as of q4 2014, nicocodine remains us fdas preferred term for this commodity. nicocodine bears us nlm identifiers umls id c0068697 and nci concept code c84008. smiles: o1c2c34c(c(n(cc3)c)cc3c4c1c(oc)cc3)c=cc2oc(=o)c1cccnc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. nicodicodine. this classification denotes an antitussive agent with the molecular formula c24h26n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 04g0t06ugt, chemically known as morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, 3-pyridinecarboxylate (ester), (5.alpha.,6.alpha.)- but more generally known as nicodicodine, which bears us nih compound identifier 522741. european medicines agency schedules nicodicodine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09235mig. the term nicodicodine is an international non-proprietary name. nicodicodine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nicodicodine under hs 29391900 and sitc 54141. as of q4 2014, nicodicodine remains us fdas preferred term for this commodity. nicodicodine bears us nlm identifiers umls id c2827287 and nci concept code c84010. smiles: o1c2c34c(c(n(cc3)c)cc3c4c1c(oc)cc3)ccc2oc(=o)c1cccnc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. normethadone. this classification denotes an opioid receptor agonist with the molecular formula c20h25no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) kr2l2a68xl, chemically known as 6-dimethylamino-4,4-diphenyl-3-hexanone but more generally known as normethadone, which bears us nih compound identifier 10090. european medicines agency schedules normethadone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09376mig. the term normethadone is an international non-proprietary name. world health organization schedules normethadone in its anatomical therapeutic chemical (atc) classification. normethadone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule normethadone under hs 29223100 and sitc 51463. as of q4 2014, normethadone remains us fdas preferred term for this commodity. normethadone bears us nlm identifiers umls id c0069008 and nci concept code c76843. smiles: o=c(c(ccn(c)c)(c1ccccc1)c1ccccc1)cc.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. pentoxyverine. this classification denotes a cyclopentane and antitussive agent with the molecular formula c20h31no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 32c726x12w, chemically known as 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentane-1-carboxylate; 2-hydroxypropane-1,2,3-tricarboxylic acid but more generally known as pentoxyverine, which bears us nih compound identifier 2562. european medicines agency schedules pentoxyverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09706mig. world health organization schedules pentoxyverine in its anatomical therapeutic chemical (atc) classification. pentoxyverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pentoxyverine under hs 29221980 and sitc 51461. as of q4 2014, pentoxyverine remains us fdas preferred term for this commodity. pentoxyverine bears us nlm identifiers umls id c0054668 and nci concept code c76471. smiles: ccn(cc)ccoccoc(=o)c1(cccc1)c2=cc=cc=c2.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. pentoxyverine citrate. this classification denotes an antitussive agent with the molecular structure c20h31no3.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 4sh0mfj5hj chemically known as cyclopentanecarboxylic acid, 1-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate (1:1), but more commonly known as pentoxyverine citrate, which bears us nih compound identifier 90010. european medicines agency schedules pentoxyverine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03695mig. most nations, for tariff and trade purposes, schedule pentoxyverine citrate under hs 29221980 and sitc 51461. as of q4 2014, pentoxyverine citrate remains us fdas preferred term for this commodity. pentoxyverine citrate bears us nlm identifiers umls id c0937606 and nci concept code c76472. smiles: ccn(cc)ccoccoc(=o)c1(cccc1)c2ccccc2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. picoperine. this classification denotes an antitussive agent with the molecular formula c19h25n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) yk3xa0k1o1, chemically known as 2-pyridinemethanamine, n-phenyl-n-(2-(1-piperidinyl)ethyl)- (9ci) but more generally known as picoperine, which bears us nih compound identifier 65701. european medicines agency schedules picoperine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09818mig. the term picoperine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). picoperine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule picoperine under hs 29333999 and sitc 51574. as of q4 2014, picoperine remains us fdas preferred term for this commodity. picoperine bears us nlm identifiers umls id c2698806 and nci concept code c76476. smiles: n1(ccccc1)ccn(cc1ncccc1)c1ccccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. viminol. this classification denotes an ethanolamine antitussive and analgesic with the molecular formula c21h31cln2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) tpv54g6xbg, chemically known as 1h-pyrrole-2-methanol, alpha-((bis(1-methylpropyl)amino)methyl)-1-((2-chlorophenyl)methyl)- but more generally known as viminol, which bears us nih compound identifier 65697. european medicines agency schedules viminol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00050mig. world health organization schedules viminol in its anatomical therapeutic chemical (atc) classification. viminol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule viminol under hs 29339990 and sitc 51577. as of q4 2014, viminol remains us fdas preferred term for this commodity. smiles: clc1c(cn2c(c(o)cn(c(cc)c)c(cc)c)ccc2)cccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. xyloxemine. this classification denotes an antitussive agent with the molecular formula c23h33no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) l95kv83pv9, chemically known as 2-(2-(di-2,6-xylylmethoxy)ethoxy)-n,n-dimethylethylamine but more generally known as xyloxemine, which bears us nih compound identifier 17800. european medicines agency schedules xyloxemine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00123mig. the term xyloxemine is an international non-proprietary name. xyloxemine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule xyloxemine under hs 29221980 and sitc 51461. as of q4 2014, xyloxemine remains us fdas preferred term for this commodity. xyloxemine bears us nlm identifiers umls id c1883581 and nci concept code c66675. smiles: o(c(c1c(cccc1c)c)c1c(cccc1c)c)ccoccn(c)c.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. pipazetate or pipazethate. this classification denotes an antitussive agent with the molecular formula c21h25n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m5ek1t5v2l, chemically known as 10h-pyrido(3,2-b)(1,4)benzothiazine-10-carboxylic acid, 2-(2-piperidinoethoxy)ethyl ester but more generally known as pipazetate, which bears us nih compound identifier 22425. european medicines agency schedules pipazetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09861mig. the term pipazetate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules pipazetate in its anatomical therapeutic chemical (atc) classification. pipazetate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. pipazetate or pipazethate bears us nlm identifiers umls id c0071099 and nci concept code c82252. smiles: c1ccn(cc1)ccoccoc(=o)n2c3=cc=cc=c3sc4=c2n=cc=c4.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. sulfogaiacol. this classification denotes an antitussive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 713aj00npg. european medicines agency schedules sulfogaiacol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10740mig. sulfogaiacol generally arises in the molecular formula c7h8o5s.k. the term sulfogaiacol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4.) sulfogaiacol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule sulfogaiacol under hs 29095010 and sitc 51617. sulfogaiacol bears us nlm identifiers umls id c0061930 and nci concept code c90776. smiles: c1=cc=c(c(=c1)oco)s(=o)(=o)[o-].[k+].. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. tipepidine. this classification denotes an opioid receptor agonist with the molecular formula c15h17ns2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 2260zp67it, chemically known as piperidine, 3-(di-2-thienylmethylene)-1-methyl- but more generally known as tipepidine, which bears us nih compound identifier 5484. european medicines agency schedules tipepidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11102mig. the term tipepidine is an international non-proprietary name. world health organization schedules tipepidine in its anatomical therapeutic chemical (atc) classification. tipepidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tipepidine under hs 29349990 and sitc 51579. as of q4 2014, tipepidine remains us fdas preferred term for this commodity. tipepidine bears us nlm identifiers umls id c0076714 and nci concept code c76847. smiles: s1c(/c(=c2\\cccn(c2)c)c2sccc2)ccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. prenoxdiazine. this classification denotes an antitussive agent with the molecular formula c23h27n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) s491hh391h, chemically known as 1-(2-(3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl)ethyl)piperidine. but more generally known as prenoxdiazine, which bears us nih compound identifier 120508. european medicines agency schedules prenoxdiazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12421mig. the term prenoxdiazine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules prenoxdiazine in its anatomical therapeutic chemical (atc) classification. prenoxdiazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule prenoxdiazine under hs 29349990 and sitc 51579. as of q4 2014, prenoxdiazine remains us fdas preferred term for this commodity. prenoxdiazine bears us nlm identifiers umls id c0138305 and nci concept code c73181. smiles: o1nc(nc1ccn1ccccc1)cc(c1ccccc1)c1ccccc1.. "
"antitussives and associated cough remedies. this classification denotes substances that suppess cough, sbstances called antitussives, thus the term antitussives and associated cough remedies.. zipeprol. this classification denotes an antitussive agent with the molecular formula c23h32n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) g5muv8139h, chemically known as 1-piperazineethanol, alpha-(alpha-methoxybenzyl)-4-(beta-methoxyphenethyl)-, dihydrochloride but more generally known as zipeprol, which bears us nih compound identifier 36909. european medicines agency schedules zipeprol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00167mig. the term zipeprol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules zipeprol in its anatomical therapeutic chemical (atc) classification. zipeprol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule zipeprol under hs 29335500 and sitc 51576. as of q4 2014, zipeprol remains us fdas preferred term for this commodity. zipeprol bears us nlm identifiers umls id c0078811 and nci concept code c66698. smiles: cl.cl.oc(cn1ccn(cc1)cc(oc)c1ccccc1)c(oc)c1ccccc1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. . "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. acetylcysteine. this classification denotes a mucolytic agent and antioxidant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) wyq7n0bpyc. european medicines agency schedules acetylcysteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05229mig. acetylcysteine generally arises in the molecular formula c5h9no3s. the term acetylcysteine is an international nomenclature of cosmetic ingredients designation. acetylcysteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule acetylcysteine under hs 29309016 and sitc 51549. as of q4 2014, acetylcysteine remains us fdas preferred term for this commodity. acetylcysteine bears us nlm identifiers umls id c0699252 and nci concept code c200. smiles: scc(nc(=o)c)c(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. ambroxol. this classification denotes a mucolytic agent and expectorant with the molecular formula c13h18br2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 200168s0cl, chemically known as trans-4-((2-amino-3,5-dibromobenzyl)amino)cyclohexanol but more generally known as ambroxol, which bears us nih compound identifier 2132. ambroxol most often comes in base and hydrochloride forms. european medicines agency schedules ambroxol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05397mig. the term ambroxol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules ambroxol in its anatomical therapeutic chemical (atc) classification. ambroxol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ambroxol under hs 29221980 and sitc 51461. as of q4 2014, ambroxol remains us fdas preferred term for this commodity. ambroxol bears us nlm identifiers umls id c0002421 and nci concept code c74262. smiles: brc1c(n)c(cnc2ccc(o)cc2)cc(br)c1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. amidephrine. this classification denotes a decongestant and an alpha-adrenergic agonist with the molecular formula c10h16n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7e2p22546v, chemically known as 3-(1-hydroxy-2-(methylamino)ethyl)methanesulfonanilide, but more generally known as amidephrine, which bears us nih compound identifier 15010. as of q4 2014, amidephrine remains us fdas preferred term for this commodity. amidephrine bears us nlm identifiers umls id c0051584 and nci concept code c79522. smiles: cncc(c1=cc(=cc=c1)ns(=o)(=o)c)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. bromhexine. this classification denotes an expectorant with the molecular formula c14h20br2n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) q1j152vb1p, chemically known as 3,5-dibromo-nalpha-cyclohexyl-nalpha-methyltoluene-alpha-2-diamine but more generally known as bromhexine, which bears us nih compound identifier 2442. bromhexine most often comes in base, chloride, and hydrochloride forms. european medicines agency schedules bromhexine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05914mig. world health organization schedules bromhexine in its anatomical therapeutic chemical (atc) classification. bromhexine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule bromhexine under hs 29215990 and sitc 51455. as of q4 2014, bromhexine remains us fdas preferred term for this commodity. smiles: brc1c(n)c(cn(c2ccccc2)c)cc(br)c1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. brovanexine. this classification denotes a mucolytic agent with the molecular formula c24h28br2n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) y00sd533iw, chemically known as 4-acetoxy-2,4-dibrom-6-((n-cyclohexylmethylamino)methyl)-3-methoxybenzanilid but more generally known as brovanexine, which bears us nih compound identifier 162137. brovanexine most often comes in base and hydrochloride forms. european medicines agency schedules brovanexine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05934mig. the term brovanexine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). brovanexine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule brovanexine under hs 29242995 and sitc 51479. as of q4 2014, brovanexine remains us fdas preferred term for this commodity. brovanexine bears us nlm identifiers umls id c0054152 and nci concept code c74261. smiles: brc1c(nc(=o)c2cc(oc)c(oc(=o)c)cc2)c(cn(c2ccccc2)c)cc(br)c1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. carbocisteine. this classification denotes a mucolytic agent with the molecular formula c5h9no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 740j2qx53r, chemically known as (rs)-cysteine, s-(carboxymethyl)- but more generally known as carbocisteine, which bears us nih compound identifier 1080. european medicines agency schedules carbocisteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11790mig. world health organization schedules carbocisteine in its anatomical therapeutic chemical (atc) classification. carbocisteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule carbocisteine under hs 29309016 and sitc 51549. smiles: scc(n)c(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. cartasteine. this classification denotes a mucolytic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) e3n11dy0ta. european medicines agency schedules cartasteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06148mig. cartasteine generally arises in the molecular formula c9h14n2o4s2. the term cartasteine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 9, no. 3, 1995, list 35.) cartasteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cartasteine under hs 29341000 and sitc 51579. as of q4 2014, cartasteine remains us fdas preferred term for this commodity. cartasteine bears us nlm identifiers umls id c2699126 and nci concept code c77597. smiles: s1cc(n(c1)c(=o)cnc(=o)c(s)c)c(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. domiodol. this classification denotes a mucolytic agent with the molecular formula c5h9io3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) c1pxf8v06n, chemically known as 1,3-dioxolane-4-methanol, 2-(iodomethyl)-, (e,z)- but more generally known as domiodol, which bears us nih compound identifier 43814. european medicines agency schedules domiodol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06355mig. the term domiodol is an international non-proprietary name. world health organization schedules domiodol in its anatomical therapeutic chemical (atc) classification. domiodol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule domiodol under hs 29329970 and sitc 51569. as of q4 2014, domiodol remains us fdas preferred term for this commodity. domiodol bears us nlm identifiers umls id c0048365 and nci concept code c65461. smiles: icc1oc(co1)co.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. cistinexine. this classification denotes a mucolytic agent and expectorant with the molecular formula c50h60br4n6o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 62vr67fk8e, chemically known as 2-oxa-7,8-dithia-4,11-diazadodecan-12-oic acid, 5,10-bis(((2,4-dibromo-6-((cyclohexylmethylamino)methyl)phenyl)amino)carbonyl)-3-oxo-1-phenyl-, phenylmethyl ester, (r-(r*,r*))- but more generally known as cistinexine, which bears us nih compound identifier 65644. european medicines agency schedules cistinexine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07484mig. the term cistinexine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 40, no. 6, 1986, list 26). cistinexine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cistinexine under hs 29309016 and sitc 51549. as of q4 2014, cistinexine remains us fdas preferred term for this commodity. cistinexine bears us nlm identifiers umls id c0627299 and nci concept code c77595. smiles: brc1c(nc(=o)c(nc(=o)occ2ccccc2)csscc(nc(=o)occ2ccccc2)c(=o)nc2c(cn(c3ccccc3)c)cc(br)cc2br)c(cn(c2ccccc2)c)cc(br)c1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. eprazinone. this classification denotes a mucolytic agent and expectorant with the molecular formula c24h32n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 883ynl63wu, chemically known as 1-propanone, 3-(4-(2-ethoxy-2-phenylethyl)-1-piperazinyl)-2-methyl-1-phenyl- but more generally known as eprazinone, which bears us nih compound identifier 3245. european medicines agency schedules eprazinone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06583mig. the term eprazinone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules eprazinone in its anatomical therapeutic chemical (atc) classification. eprazinone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule eprazinone under hs 29335995 and sitc 51576. as of q4 2014, eprazinone remains us fdas preferred term for this commodity. eprazinone bears us nlm identifiers umls id c0059469 and nci concept code c65518. smiles: o(c(cn1ccn(cc1)cc(c)c(=o)c1ccccc1)c1ccccc1)cc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. erdosteine. this classification denotes a mucolytic agent with the molecular formula c8h11no4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 76j0853eka, chemically known as acetic acid, ((2-oxo-2-((tetrahydro-2-oxo-3-thienyl)amino)ethyl)thio)- but more generally known as erdosteine, which bears us nih compound identifier 65632. european medicines agency schedules erdosteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06595mig. the term erdosteine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules erdosteine in its anatomical therapeutic chemical (atc) classification. erdosteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule erdosteine under hs 29349990 and sitc 51579. as of q4 2014, erdosteine remains us fdas preferred term for this commodity. erdosteine bears us nlm identifiers umls id c0059506 and nci concept code c61750. smiles: s1ccc(nc(=o)cscc(=o)o)c1=o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. fudosteine. this classification denotes a mucolytic agent with the molecular formula c6h13no3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) ur9vpi71pt, chemically known as l-cysteine, s-(3-hydroxypropyl)- but more generally known as fudosteine, which bears us nih compound identifier 134669. european medicines agency schedules fudosteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07825mig. the term fudosteine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 12 no. 1 1998, list 39). fudosteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fudosteine under hs 29309016 and sitc 51549. as of q4 2014, fudosteine remains us fdas preferred term for this commodity. fudosteine bears us nlm identifiers umls id c0756016 and nci concept code c65777. smiles: s(cc(n)c(=o)o)ccco.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol. this classification denotes an anti-infective agent and expectorant with the molecular formula c7h8o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 6jka7mah9c, chemically known as phenol, o-methoxy- but more generally known as guaiacol, which bears us nih compound identifier 460. european medicines agency schedules guaiacol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14027mig. most nations, for tariff and trade purposes, schedule guaiacol under hs 29095000 and sitc 51617. as of q4 2014, guaiacol remains us fdas preferred term for this commodity. guaiacol bears us nlm identifiers umls id c0018304 and nci concept code c76663. smiles: o(c1c(o)cccc1)c.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol acetate. this classification denotes a topical anti-infective agent and expectorant with the molecular formula c9h10o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k5yn7743hc, chemically known as phenol, 2-methoxy-, 1-acetate, but more generally known as guaiacol acetate, which bears us nih compound identifier 61155. european medicines agency schedules guaiacol acetate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14027mig. most nations, for tariff purposes, schedule guaiacol acetate under hs 29095000. smiles: cc(=o)oc1ccccc1oc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol benzoate. this classification denotes a topical anti-infective agent and expectorant with the molecular formula c14h12o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier odw913za6p, chemically known as phenol, 2-methoxy-, 1-benzoate, but more generally known as guaiacol benzoate, which bears us nih compound identifier 68272. european medicines agency schedules guaiacol benzoate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14027mig. most nations, for tariff purposes, schedule guaiacol benzoate under hs 29095000. smiles: coc1ccccc1oc(=o)c2ccccc2.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol butyrate. this classification denotes a topical anti-infective agent and expectorant with the molecular formula c11h14o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 48936e6ftm, chemically known as butanoic acid, 2-methoxyphenyl ester but more generally known as guaiacol butyrate, which bears us nih compound identifier 77756. most nations, for tariff and trade purposes, schedule guaiacol butyrate under hs 29095000. as of q4 2014, guaiacol butyrate remains us fdas preferred term for this commodity. smiles: cccc(=o)oc1ccccc1oc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol carbonate. this classification denotes an expectorant with the molecular formula c15h14o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q71xpq6r29, chemically known as phenol, 2-methoxy-, carbonate (2:1) (9ci) but more generally known as guaiacol carbonate, which bears us nih compound identifier 11104. european medicines agency schedules guaiacol carbonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14028mig. most nations, for tariff and trade purposes, schedule guaiacol carbonate under hs 29095000 and sitc 51617. as of q4 2014, guaiacol carbonate remains us fdas preferred term for this commodity. guaiacol carbonate bears us nlm identifiers umls id c0771805 and nci concept code c76056. smiles: coc1ccccc1oc(=o)oc2ccccc2oc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol nicotinate. this classification denotes a topical anti-infective agent and expectorant with the molecular formula c13h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0nl78157rr. most nations, for tariff and trade purposes, schedule guaiacol nicotinate under hs 29095000 and sitc 51617. as of q4 2014, guaiacol nicotinate remains us fdas preferred term for this commodity. smiles: coc1ccccc1oc(=o)c2cccnc2.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol phenylacetate. this classification denotes a topical anti-infective agent and expectorant with the molecular formula c15h14o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier llo759386w, chemically known as acetic acid, phenyl-, o-methoxyphenyl ester, but more generally known as guaiacol phenylacetate, which bears us nih compound identifier 61331. european medicines agency schedules guaiacol phenylacetate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14027mig. most nations, for tariff purposes, schedule guaiacol phenylacetate under hs 29095000. smiles: coc1ccccc1oc(=o)cc2ccccc2.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. letosteine. this classification denotes a mucolytic agent with the molecular formula c10h17no4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 6mvf9u95dw, chemically known as 4-thiazolidinecarboxylic acid, 2-(2-((2-ethoxy-2-oxoethyl)thio)ethyl)- but more generally known as letosteine, which bears us nih compound identifier 68707. european medicines agency schedules letosteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08442mig. the term letosteine is an international non-proprietary name. world health organization schedules letosteine in its anatomical therapeutic chemical (atc) classification. letosteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule letosteine under hs 29341000 and sitc 51579. as of q4 2014, letosteine remains us fdas preferred term for this commodity. letosteine bears us nlm identifiers umls id c0064777 and nci concept code c80974. smiles: ccoc(=o)csccc1nc(cs1)c(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. mecysteine. this classification denotes a mucolytic agent with the molecular formula c4h9no2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) rq6l463n3b, chemically known as methyl cysteine, hydrochloride but more generally known as mecysteine, which bears us nih compound identifier 4040. european medicines agency schedules mecysteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08688mig. the term mecysteine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). mecysteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mecysteine under hs 29309016 and sitc 51549. as of q4 2014, mecysteine remains us fdas preferred term for this commodity. mecysteine bears us nlm identifiers umls id c0065850 and nci concept code c66067. smiles: scc(n)c(=o)oc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. moguisteine. this classification denotes a mucolytic agent with the molecular formula c16h21no5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 6y556547yy, chemically known as 3-thiazolidinepropanoic acid, 2-((2-methoxyphenoxy)methyl)-beta-oxo-, ethyl ester, (+-)- but more generally known as moguisteine, which bears us nih compound identifier 65935. european medicines agency schedules moguisteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09038mig. the term moguisteine is an international non-proprietary name. most nations, for tariff and trade purposes, schedule moguisteine under hs 29341000 and sitc 51579. as of q4 2014, moguisteine remains us fdas preferred term for this commodity. moguisteine bears us nlm identifiers umls id c0256172 and nci concept code c66178. smiles: s1c(n(cc1)c(=o)cc(=o)occ)coc1c(oc)cccc1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol phosphate. this classification denotes a topical anti-infective agent and expectorant with the molecular formula c21h21o7p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56492o1f0u, chemically known as phenol, 2-methoxy-, phosphate (3:1), but more generally known as guaiacol phosphate, which bears us nih compound identifier 68420. european medicines agency schedules guaiacol phosphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14027mig. most nations, for tariff purposes, schedule guaiacol phosphate under hs 29095000. smiles: coc1ccccc1op(=o)(oc2ccccc2oc)oc3ccccc3oc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. isalsteine. this classification denotes a mucolytic agent with the molecular formula c14h15no6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) k0ypy57fuq, chemically known as (- )-n-(2-((2-methyl-4-oxo-1,3-benzodioxan-2-yl)thio)propionyl)glycine. but more generally known as isalsteine, which bears us nih compound identifier 3038474. european medicines agency schedules isalsteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08302mig. the term isalsteine is an international non-proprietary name. isalsteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule isalsteine under hs 29329970 and sitc 51569. as of q4 2014, isalsteine remains us fdas preferred term for this commodity. isalsteine bears us nlm identifiers umls id c1881271 and nci concept code c65967. smiles: s(c1(oc2c(c(=o)o1)cccc2)c)c(c)c(=o)ncc(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaiacol propionate. this classification denotes a topical anti-infective agent and expectorant with the molecular formula c10h12o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z7sco70q61. most nations, for tariff and trade purposes, schedule guaiacol propionate under hs 29095000. as of q4 2014, guaiacol propionate remains us fdas preferred term for this commodity. smiles: ccc(=o)oc1ccccc1oc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaietolin. this classification denotes an expectorant with the molecular formula c11h16o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) g9j54386jh, chemically known as 1,2-propanediol, 3-(o-ethoxyphenoxy)- but more generally known as guaietolin, which bears us nih compound identifier 68825. european medicines agency schedules guaietolin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07972mig. the term guaietolin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). guaietolin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule guaietolin under hs 29094990 and sitc 51617. as of q4 2014, guaietolin remains us fdas preferred term for this commodity. guaietolin bears us nlm identifiers umls id c0771575 and nci concept code c83739. smiles: ccoc1=cc=cc=c1occ(co)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. guaifenesin. this classification denotes an expectorant with the molecular formula c10h14o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 495w7451vq, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears us nih compound identifier 3516. european medicines agency schedules guaifenesin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07973mig. the term guaifenesin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules guaifenesin in its anatomical therapeutic chemical (atc) classification. guaifenesin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule guaifenesin under hs 29094990 and sitc 51617. as of q4 2014, guaifenesin remains us fdas preferred term for this commodity. guaifenesin bears us nlm identifiers umls id c0018305 and nci concept code c29081. smiles: coc1=cc=cc=c1occ(co)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. naphazoline. this classification denotes an alpha-adrenergic agonist with the molecular formula c14h14n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) h231gf11bv, chemically known as 4,5-dihydro-2-(1-naphthylmethyl)imidazole but more generally known as naphazoline, which bears us nih compound identifier 4436. european medicines agency schedules naphazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09154mig. the term naphazoline is an international non-proprietary name. world health organization schedules naphazoline in its anatomical therapeutic chemical (atc) classification. naphazoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule naphazoline under hs 29332990 and sitc 51573. as of q4 2014, naphazoline remains us fdas preferred term for this commodity. naphazoline bears us nlm identifiers umls id c0027373 and nci concept code c61856. smiles: n1c(=ncc1)cc1c2c(ccc1)cccc2.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. neltenexine. this classification denotes a mucolytic agent with the molecular formula c18h20br2n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) u942dgm90x, chemically known as 4,6-dibromo-alpha-((trans-4-hydroxycyclohexyl)amino)-2-thiophene-carboxy-o-toluidide but more generally known as neltenexine, which bears us nih compound identifier 3047787. european medicines agency schedules neltenexine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09187mig. the term neltenexine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules neltenexine in its anatomical therapeutic chemical (atc) classification. neltenexine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule neltenexine under hs 29349990 and sitc 51579. as of q4 2014, neltenexine remains us fdas preferred term for this commodity. neltenexine bears us nlm identifiers umls id c0382131 and nci concept code c90885. smiles: brc1c(nc(=o)c2sccc2)c(cnc2ccc(o)cc2)cc(br)c1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. nesosteine. this classification denotes a mucolytic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 445j9k442z. european medicines agency schedules nesosteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09208mig. nesosteine generally arises in the molecular formula c11h11no3s. the term nesosteine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25.) nesosteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nesosteine under hs 29341000 and sitc 51579. as of q4 2014, nesosteine remains us fdas preferred term for this commodity. nesosteine bears us nlm identifiers umls id c0068574 and nci concept code c66233. smiles: c1cscn1c(=o)c2=cc=cc=c2c(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. oxedrine. this classification denotes an adrenergic alpha-agonist, nasal decongestant, sympathomimetic, and vasoconstrictor agent with the molecular formula c9h13no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier peg5dp7434, chemically known as benzyl alcohol, p-hydroxy-alpha-((methylamino)methyl)- but more generally known as oxedrine, which bears us nih compound identifier 7172. european medicines agency schedules oxedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14726mig. world health organization schedules oxedrine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, oxedrine remains us fdas preferred term for this commodity. smiles: oc(cnc)c1ccc(o)cc1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. oxymetazoline. this classification denotes an alpha-adrenergic agonist with the molecular formula c16h24n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 8vln5b44zy, chemically known as 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol but more generally known as oxymetazoline, which bears us nih compound identifier 4636. european medicines agency schedules oxymetazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09567mig. the term oxymetazoline is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules oxymetazoline in its anatomical therapeutic chemical (atc) classification. oxymetazoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule oxymetazoline under hs 29332990 and sitc 51573. as of q4 2014, oxymetazoline remains us fdas preferred term for this commodity. oxymetazoline bears us nlm identifiers umls id c0030071 and nci concept code c61871. smiles: oc1c(c(c)(c)c)cc(c(c1c)cc1=nccn1)c.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. prenisteine. this classification denotes a mucolytic agent with the molecular formula c8h15no2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 99ta452185, chemically known as l-alanine, 3-((3-methyl-2-butenyl)thio)- but more generally known as prenisteine, which bears us nih compound identifier 21359. european medicines agency schedules prenisteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10028mig. the term prenisteine is an international non-proprietary name. prenisteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule prenisteine under hs 29309016 and sitc 51549. as of q4 2014, prenisteine remains us fdas preferred term for this commodity. prenisteine bears us nlm identifiers umls id c2347668 and nci concept code c73134. smiles: s(cc(n)c(=o)o)c/c=c(/c)c.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. pseudoephedrine. this classification denotes an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears us nih compound identifier 5032. european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification. pseudoephedrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pseudoephedrine under hs 29394200 and sitc 54144. as of q4 2014, pseudoephedrine remains us fdas preferred term for this commodity. pseudoephedrine bears us nlm identifiers umls id c0033798 and nci concept code c61914. smiles: cc(c(c1=cc=cc=c1)o)nc.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. naphazoline nitrate. this classification denotes an alpha-adrenergic agonist with the molecular formula c14h14n2.hno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sc99gr1t5s, chemically known as 2-imidazoline, 2-(1-naphthylmethyl)-, mononitrate but more generally known as naphazoline nitrate, which bears us nih compound identifier 21225. european medicines agency schedules naphazoline nitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03390mig. most nations, for tariff and trade purposes, schedule naphazoline nitrate under hs 29332990 and sitc 51573. naphazoline nitrate bears us nlm identifiers umls id c0770988 and nci concept code c98243. as of q4 2014, naphazoline nitrate remains us fdas preferred term for this commodity. smiles: c1ccc2c(c1)cccc2cc3=nccn3.[n+](=o)(o)[o-].. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. pseudoephedrine sulfate. this classification denotes an alpha-adrenergic agonist with the molecular formula 2c10h15no.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y9dl7qpe6b, chemically known as bis((s-(r*,r*))-(beta-hydroxy-alpha-methylphenethyl)methylammonium) sulphate but more generally known as pseudoephedrine sulfate, which bears us nih compound identifier 62945. european medicines agency schedules pseudoephedrine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15044mig. most nations, for tariff and trade purposes, schedule pseudoephedrine sulfate under hs 29394200 and sitc 54144. as of q4 2014, pseudoephedrine sulfate remains us fdas preferred term for this commodity. pseudoephedrine sulfate bears us nlm identifiers umls id c0304431 and nci concept code c47696. smiles: c[c@@h]([c@h](c1ccccc1)o)nc.c[c@@h]([c@h](c1ccccc1)o)nc.os(=o)(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. pseudoephedrine tannate. this classification denotes an alpha-adrenergic agonist with the molecular formula c76h52o46.c10h15no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 82w1ij29at. european medicines agency schedules pseudoephedrine tannate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20399. most nations, for tariff and trade purposes, schedule pseudoephedrine tannate under hs 29394200 and sitc 54144. as of q4 2014, pseudoephedrine tannate remains us fdas preferred term for this commodity. smiles: none.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. sobrerol. this classification denotes an expectorant with the molecular formula c10h18o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ai0nx02o35, chemically known as 5-hydroxy-alpha,alpha,4-trimethylcyclohex-3-ene-1-methanol but more generally known as sobrerol, which bears us nih compound identifier 91463. european medicines agency schedules sobrerol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15264mig. world health organization schedules sobrerol in its anatomical therapeutic chemical (atc) classification. as of q4 2014, sobrerol remains us fdas preferred term for this commodity. smiles: cc1=ccc(cc1o)c(c)(c)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. stepronin. this classification denotes a mucolytic agent with the molecular formula c10h11no4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 0noy894qrb, chemically known as glycine, n-(1-oxo-2-((2-thienylcarbonyl)thio)propyl)- but more generally known as stepronin, which bears us nih compound identifier 54120. european medicines agency schedules stepronin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10645mig. the term stepronin is an international non-proprietary name. world health organization schedules stepronin in its anatomical therapeutic chemical (atc) classification. stepronin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule stepronin under hs 29349990 and sitc 51579. as of q4 2014, stepronin remains us fdas preferred term for this commodity. stepronin bears us nlm identifiers umls id c0075227 and nci concept code c74264. smiles: cc(c(=o)ncc(=o)o)sc(=o)c1=cc=cs1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. tasuldine. this classification denotes a mucolytic agent with the molecular formula c10h9n3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) s4zce64q3o, chemically known as pyrimidine, 2-((3-pyridinylmethyl)thio)- but more generally known as tasuldine, which bears us nih compound identifier 65666. european medicines agency schedules tasuldine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10835mig. the term tasuldine is an international non-proprietary name. tasuldine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tasuldine under hs 29335995 and sitc 51576. as of q4 2014, tasuldine remains us fdas preferred term for this commodity. tasuldine bears us nlm identifiers umls id c0626803 and nci concept code c74551. smiles: c1=cc(=cn=c1)csc2=nc=cc=n2.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. taurosteine. this classification denotes a mucolytic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 43a07ph183. european medicines agency schedules taurosteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10840mig. taurosteine generally arises in the molecular formula c7h9no4s2. the term taurosteine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 5, no. 3 1991, list 31.) taurosteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule taurosteine under hs 29349990 and sitc 51579. as of q4 2014, taurosteine remains us fdas preferred term for this commodity. taurosteine bears us nlm identifiers umls id c2699896 and nci concept code c74549. smiles: s(=o)(=o)(o)ccnc(=o)c1sccc1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. telmesteine. this classification denotes a mucolytic agent with the molecular formula c7h11no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 124i3fe35t, chemically known as (-)-3-ethyl hydrogen (r)-3,4-thiazolidinedicarboxylate but more generally known as telmesteine, which bears us nih compound identifier 65946. european medicines agency schedules telmesteine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10873mig. the term telmesteine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 5, no. 3 1991, list 31). telmesteine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule telmesteine under hs 29341000 and sitc 51579. as of q4 2014, telmesteine remains us fdas preferred term for this commodity. telmesteine bears us nlm identifiers umls id c0293153 and nci concept code c74550. smiles: s1cc(n(c1)c(=o)occ)c(=o)o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. terpin hydrate. this classification denotes a menthol analog, insect repellent, and expectorant with the molecular formula c10h20o2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s3v868548t, chemically known as 1,8-terpin but more generally known as terpin hydrate, which bears us nih compound identifier 6651. european medicines agency schedules terpin hydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15488mig. as of q4 2014, terpin hydrate remains us fdas preferred term for this commodity. smiles: cc1(ccc(cc1)c(c)(c)o)o.o.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. tetrahydrozoline or tetryzoline. this classification denotes an alpha-adrenergic agonist with the molecular formula c13h16n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s9u025y077, chemically known as 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazole but more generally known as tetrahydrozoline, which bears us nih compound identifier 5419. european medicines agency schedules tetryzoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10955mig. the term tetryzoline is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules tetrahydrozoline in its anatomical therapeutic chemical (atc) classification. as of q4 2014, tetrahydrozoline remains us fdas preferred term for this commodity. tetrahydrozoline bears us nlm identifiers umls id c0076286 and nci concept code c61967. smiles: c1cc(c2=cc=cc=c2c1)c3=nccn3.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. tiopronin. this classification denotes an agent affecting blood and body fluid with the molecular formula c5h9no3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) c5w04go61s, chemically known as glycine, n-(2-mercaptopropionyl)- but more generally known as tiopronin, which bears us nih compound identifier 5483. european medicines agency schedules tiopronin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11089mig. the term tiopronin is an international non-proprietary name. world health organization schedules tiopronin in its anatomical therapeutic chemical (atc) classification. tiopronin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tiopronin under hs 29309085 and sitc 51549. as of q4 2014, tiopronin remains us fdas preferred term for this commodity. tiopronin bears us nlm identifiers umls id c0025405 and nci concept code c47758. smiles: sc(c(=o)ncc(=o)o)c.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. tyloxapol. this classification denotes a surface-active agent with the molecular formula (c15h22o(c2h4o)n)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y27pul9h56, chemically known as 4-(1,1,3,3-tetramethylbutyl)phenol, polymer with formaldehyde & oxirane but more generally known as tyloxapol, which bears us nih compound identifier 71388. european medicines agency schedules tyloxapol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05015mig. world health organization schedules tyloxapol in its anatomical therapeutic chemical (atc) classification. as of q4 2014, tyloxapol remains us fdas preferred term for this commodity. tyloxapol bears us nlm identifiers umls id c0077539 and nci concept code c80949. smiles: cc(c)(c)cc(c)(c)c1=cc=c(c=c1)o.c=o.c1co1.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. xylometazoline. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h24n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) wpy40fth8k, chemically known as 2-imidazoline, 2-(4-tert-butyl-2,6-dimethylbenzyl)- but more generally known as xylometazoline, which bears us nih compound identifier 5709. european medicines agency schedules xylometazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00122mig. the term xylometazoline is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules xylometazoline in its anatomical therapeutic chemical (atc) classification. xylometazoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule xylometazoline under hs 29332990 and sitc 51573. as of q4 2014, xylometazoline remains us fdas preferred term for this commodity. xylometazoline bears us nlm identifiers umls id c0078643 and nci concept code c87749. smiles: n1c(=ncc1)cc1c(cc(c(c)(c)c)cc1c)c.. "
"decongestants, expectorants, and mucolytics. this classification denotes drugs that a) treat nasal passage inflammation, substances called decongestants; and/or b) increase mucous excretion, substances called expectorants and/or mucolytics, thus the term decongestants, expectorants, and mucolytics.. sterile water for inhalation. sterilized water used in nebulizers or for nasal rinses.. "
